Lipid profile in pregnancy by Catherine, S
[1] 
 
                  ‘LIPID PROFILE IN PREGNANCY’     
 
 
 
 
 
 
 
 
 
 
 
 
                                  
 
 
 
 
 
DISSERTATION SUBMITTED IN PARTIAL FULFILMENT OF THE 
REQIUREMENTS OF TAMIL  NADU  DR.M.G.R  MEDICAL  UNIVERSITY  
FOR  THE  DEGREE OF  M.S. BRANCH II  (OBSTETRICS AND 
GYNAECOLOGY) EXAMINATION TO BE HELD IN  APRIL 2014 
[2] 
 
                                            CERTIFICATE 
 This is to certify that the dissertation entitled “LIPID PROFILE IN PREGNANCY” is 
the original work of Dr.Catherine.S  done under my guidance towards the M.S. 
Branch II (Obstetrics and Gynecology) Degree Examination of Tamil Nadu Dr. 
M.G.R Medical University, Chennai to be held in April 2014. 
 
 
Signature  
 
 
Guide: 
Dr. Annie Regi,MD,DGO, 
Professor, Unit III, 
Department of Obstetrics and Gynecology, 
Christian Medical College, 
Vellore – 632 004. 
  
 
 
[3] 
 
                                      CERTIFICATE 
This is to certify that the dissertation entitled “LIPID PROFILE IN PREGNANCYˮ is 
the original work of Dr.Catherine.S  done towards the M.S. Branch II (Obstetrics and 
Gynecology) Degree Examination of Tamil Nadu Dr. M.G.R Medical University, 
Chennai to be held in April 2014. 
 
 
 
 
Dr. Alfred Job Daniel,                                                 Dr. Abraham Peedicayil, 
The Principal       Professor and Head, 
Christian Medical College,  Department of  Obstetrics and  Gynecology 
Vellore – 632 004.                                         Christian Medical College, 
                                                                                 Vellore – 632 004 
 
 
 
 
 
 
[4] 
 
                           Anti Plagiarism Certificate 
 
 
 
[5] 
 
                                   IRB APPROVAL  FORM 
 
 
 
 
 
[6] 
 
 
 
 
[7] 
 
 
[8] 
 
                                   ACKNOWLEDGEMENTS 
                                 
First and foremost, I thank my Lord Jesus Christ , for showering me with His 
abundant grace and thus enabling me to complete this thesis. 
 I owe gratitude to Dr. Annie Regi (Guide) and Dr. Elsy Thomas (Co- guide) for all 
their guidance and support.  
I extend my heartfelt and sincere thanks to Dr. Thomas Paul for idea conceptualisation 
and Dr. Nihal Thomas, for their assistance in funding,  formatting , and editing this 
work.  
This would not have been feasible if not for the help rendered by Dr. Selvakumar  and 
his team ,from the Department of Biochemistry in the area of sample analysis.  
 The assistance provided by the biostatisticians Dr. Antonisamy, Dr. Tunney and Miss 
Gowri was invaluable. This is also an opportunity for me to place on record the aid of 
the Medical Record Officers Mr. Kusmos and Mr. Christopher and the radiology 
assistants Mrs. Narayani, Mrs. Lilly and Mrs. Maya in the recruitment and follow up 
of the involved women.  
Miss Banu and Mr. Muthukumar played a key role in data entry and data analysis. In 
addition, I would like to acknowledge the efforts put in by my co-PG registrars  in the 
follow up of the women involved in the study. I also acknowledge the assistance by 
Mrs.Usha , our office secretary , an ever smiling and ever helpful person. 
 Last but not the least my family, my husband Dr. Arun Immanuel ,my two daughters 
Bettina and Danita, my parents and my in-laws , for all their  prayers, patience and 
love. 
[9] 
 
                                  TABLE OF CONTENTS 
 
• Introduction   ----------------------------------------------            10 
 
• Aims and objective    -------------------------------------            13 
 
• Literature review    ----------------------------------------            14 
 
• Materials and Methodology     --------------------------             48 
 
• Results and Analysis      ----------------------------------            53 
 
• Discussion      ----------------------------------------------            81 
 
• Conclusion       ---------------------------------------------            89 
 
• Limitation       ----------------------------------------------            90 
 
• Bibliography       ------------------------------------------             92 
 
•  Appendix      ---------------------------------------------           100 
 
•   Data        -------------------------------------------------             104 
 
 
 
 
 
 
 
 
[10] 
 
                               INTRODUCTION 
 Cardivascular disease is one of the leading cause of death among women.The 
prevalence of obesity  and metabolic syndrome leading to increased mortality and 
morbidity due to cardiovascular disease and type 2  Diabetes Mellitus is very rapidly 
increasing in India and other South Asian countries. This is predominantly due to 
rapid nutritional changes, life style and socio economic transition ,increasing 
affluence, urbanisation, mechanisation and rural to urban migration. 
Atherogenic dyslipidemia, glucose intolerance, thrombotic tendency ,subclinical 
inflammation and endothelial dysfunction are proportionately higher amongst Asian 
Indians compared to Caucasians. The South Asian phenotype is characterised by 
increased waist circumference, increased waist to hip ratio, excessive body fat mass, 
increased plasma insulin levels, insulin resistance and atherogenic dyslipidemia with 
low levels of HDL and high triglyceride levels.(1) The ‘Fetal origins’  hypothesis 
connects adulthood hypertension, insulin resisitance, dyslipidemia  to adverse intra 
uterine conditions during pregnancy  that might be associated with disproportionate 
fetal growth .Growth restricted babies are more prone for adult metabolic disorders, 
higher diastolic blood  pressure(2) and macrosomic babies with accelerated fetal 
growth being  predisposed to subsequent  obesity and gestational Diabetes mellitus.(3) 
Variations  in birth weight are strongly determined by neonatal fat mass . Fetal growth 
disorders might result from variations in maternal and fetal lipid metabolism 
(4,5).More than 90 % of fat deposition in the fetus occurs during  the last 10 weeks of 
pregnancy , increasing exponentially  to reach a rate of 7 g/day close to term(6).Hence 
the importance arises, to know the  lipid and lipoprotein ratios in pregnancy. By the  
third trimester , most women have a lipid profile which is considered highly 
atherogenic in the non pregnant state(7).Animal model studies show that maternal 
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hypercholesterolemia during pregnancy , though temporary triggers pathogenic events 
in the fetal aorta enhancing atherogenesis later in life.(8) 
As early as 1934,Eldon.M.Boyd  published an article on “The Lipemia of pregnancy” 
as maternal serum was described as milky “adipositas sanguinas”. He concluded that 
‘neutral fat’   begins to rise in pregnancy and reaches 100%(compared to non pregnant 
women) by the  third trimester, whereas phospholipid and cholesterol increase from 
the 2nd trimester onwards and  may reach a level , which is  25%  greater  than non 
pregnant women by 3rd trimester.(9) 
A supraphysiological  rise in plasma lipids (>95th percentile) in pregnancy may serve 
as a marker for “pre lipemia” in the same way gestational diabetes is a marker for pre 
diabetes(10). 
Physiological increases in maternal TC,HDL,LDL&TGL are  needed for development 
of cell membranes, steroid synthesis, cell proliferation&  differentiation, metabolic 
regulation & fetal growth(11). The increase in lipid and lipoprotein ratios in 
pregnancy is highly influenced by (a) Genetic factors .(b)Medical complications of 
pregnancy.(c) Pre existing medical conditions. Overweight and obese women have 
different lipid profiles during pregnancy than their normal-weight peers. This 
difference may be the result of metabolic dysregulation associated with maternal 
overweight and obesity that mediates the increased risk of adverse outcomes found in 
these women.(12) 
Hence this study “LIPID PROFILE IN PREGNANCY ” was carried out, to obtain 
the range of lipid profile values (in three trimesters) in normal pregnancy in South 
Indian pregnant women .With the rise in the incidence of GDM among Asian women 
[12] 
 
,this study will also help in determining the early changes in lipid profile that might 
predict developing GDM later on in pregnancy. 
        In view of the strong evidence correlating infant birthweight with adult onset 
hypertension, dyslipidemia, insulin resistance and obesity ,this study aims at finding  
if there is an association between maternal lipids to changes in infant birth weight. 
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                                        AIMS AND OBJECTIVES 
i)To assess the longitudinal changes in  lipid profile during the three trimesters 
of normal pregnancy. 
ii)To determine ,  if alterations in lipid profile in each trimester may be  
associated with changes in  new born’s  birthweight. 
iii)To determine  if adverse pregnancy outcomes such as gestational 
hypertension and gestational diabetes mellitus, are associated with altered lipid 
profile. 
 
 
                                              
 
                                  
 
 
 
 
 
 
 
                                  
 
                              LITERATURE REVIEW
 
Definition of LIPID: “
solvents ( such as chloroform and ether), that are usually insoluble in water, that with 
proteins and carbohydrates constitute the principal structural components of 
cells, and that include fats, waxes, phosphatides, cerebrosides, and related and derived 
compounds”(13).The term ‘LIPID’ was first used by German Biochemist Bloor in 
1943. 
Lipids are classified into 8 broad categories
Source :Biologyexams 4 u,Google images
Fatty acyls FA ,Glycerolipids, Glycerophospholipids ,Sphingolipids,Sterol lipids 
,Prenol lipids ,Saccharolipids ,Polyketides 
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 any of various substances that are soluble in non polar organic 
; 
 
(14).  
living 
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Lipids, such as cholesterol and triglycerides, are insoluble in plasma .They are carried 
by lipoproteins  to various tissues for energy utilization, lipid deposition, steroid 
hormone production, and bile acid formation.  
Structure of a lipoprotein: 
 
Source : Antonio Zamora,Scientificpsychic.com 
Lipoproteins have a lipid and a protein component. The lipid component is occupied 
by cholesterol, Triglycerides and phospholipids. The protein component is called 
Apolipoprotein. These apoproteins act as cofactors for enzymes and ligands for 
receptors.  
Lipoproteins are classified into 5 groups: 
1. Chylomicrons. 
2. VLDL. 
3. IDL. 
4. LDL. 
5. HDL. 
[16] 
 
 
Source :Medscape.com 
 
Source : JM Saland, H. G. (2007). "Lipoprotein metabolism in chronic renal 
insufficiency." Pediatr Nephrol 22: 1095-1112 
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Source :TooSogiE Lipid diagnostics 
1.Chylomicrons : They are large particles and they carry dietary lipid from intestine to 
liver, skeletal muscle and adipose tissue. 
  
Source : people upei.ca 
2.VLDL (Very Low Density Lipoprotein):They carry most of the endogenous , newly 
synthesised triglycerides and cholesterol to a lesser extent from liver to adipose tissue. 
3.IDL (Intermediate Density Lipoprotein ):They carry cholesterol esters and 
triglycerides. 
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4.LDL(Low Density Lipoprotein ): They carry cholesterol esters from liver to cells of 
the body. 
 
Source :Sigma aldrich.com 
5.HDL (High Density Lipoprotein ): They carry cholesterol esters from the peripheral 
tissues and return to the liver. 
 
 
LIPID METABOLISM:1.Exogenous pathway. 
                                       2.Endogenous pathway . 
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EXOGENOUS PATHWAY:
 
Source : syontix.com 
The pathway starts with intestinal cell absorbing dietary cholesterol and free fatty 
acids. Within the cell, fatty acids combine with glycerols to form triglycerides. 
Cholesterol undergoes esterification by the action of Acyl co A cholesterol acyl 
transferase(ACAT) to form cholesterol esters. Triglycerides and cholesterol esters are 
assembled into chylomicrons within the cell. The main apoprotein attached to the 
chylomicron being B-48 which prevents the chylomicron getting attached to LDL 
receptors.  
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Source : www.docstoc.com 
Once the chylomicrons enter the circulation, apo C-II and Apo –E are acquired. Apo 
C-II acts as a cofactor for Lipoprotein lipase from the tissues to act on the 
chylomicrons which then releases the free fatty acids produced by the hydrolysis to 
breakdown the core triglyceride. Free fatty acids are absorbed by the tissues as energy 
source or converts back to triglycerides for storage. The end product of chylomicron 
breakdown, the smaller chylomicron remnants are absorbed by their respective 
receptors in the liver which is later used in the production of HDL. 
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ENDOGENOUS PATHWAY: 
 
Source : www.studyblue.com 
This begins with the hepatic production of VLDL.VLDL contains 60 % of 
triglycerides and 20 % of cholesterol esters. Microsomal triglyceride transfer protein 
(MTP) (15)is an intracellular lipid transfer protein that aids in transfer of triglycerides 
mainly to apolipoprotein B found in the liver. 
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Source : www.fracp.bigpondhosting.com 
The other surface apolipoprotein C-II acts as a cofactor for the action of Lipoprotein 
lipase, Apo C-III inhibits it, Apo B and E serve as ligands for LDL receptors. VLDL is 
acted upon by lipoprotein lipase in tissues such as adipose tissue and muscle where the 
lipid core , mainly triglycerides are broken into glycerols and fatty acids. When VLDL 
loses most of it’s triglyceride, it becomes smaller to become IDL, which is then 
absorbed by the liver to form LDL with more cholesterol content using hepatic 
lipase.LDL enters the circulation to be taken up the tissues via the LDL receptors. Any 
excess LDL is reabsorbed in the liver. 
LDL (Low density lipoprotein): 
LDL particles contain  a core of cholesterol esters and lesser amount of triglycerides 
,and has an abundance of apo B-100 which serves as a ligand to bind to LDL 
receptors.LDL acts on hepatic and non hepatic tissues. In hepatic tissues, LDL is 
converted to bile acids and secreted into the intestinal lumen. In non hepatic tissues, 
LDL is used for hormone synthesis, cell membrane synthesis  or stored as esterified 
fat. 
The uptake of LDL intracellularly  is controlled by the apoB/E LDL receptor 
expression by negative feedback mechanism(16). 
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Source :www.gbhealthwatch.com 
When there is excessive of cholesterol, the receptor is down regulated. When the 
intracellular cholesterol decreases as expressed by a decrease in HMG Co A reductase, 
induces expression of LDL receptors leading to an increase in uptake. 
 
Source:www.biocarta.com/pathfiles 
LDL can enter macrophages and other tissues by an unregulated scavenger receptor, 
leading to excess cholesterol within the cell, which forms foam cells .This predisposes 
to the formation of atheromatous plaques. 
HDL (High density lipoprotein ): 
HDL is synthesised in the liver and intestine , composed of phospholipids and 
apolipoproteins. Triglyceride depleted VLDL and chylomicrons provide the necessary 
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surface components like phospholipids, cholesterol and lipoproteins . Apolipoprotein 
A-I , on the surface of HDL serves to mobilise (unesterified) cholesterol from the 
tissues into the HDL particles by diffusion where it is esterified to cholesterol ester by 
LCAT , a plasma enzyme which is controlled by apolipoprotein A-I. HDL also accepts 
cholesterol released from lipolysis of triglyceride containing lipoproteins. 
 
Source: www.aacc.org/publications 
A cholesterol reflux regulatory protein plays a major role in the transfer of 
intracellular cholesterol to the cell membrane where it is taken up by HDL(17).CETP 
(Cholesterol ester transfer protein ) aids in the take up of these newly formed 
cholesterol ester by the apoplipoprotein B containing lipoproteins like VLDL,IDL and 
LDL which is then utilised for steroid synthesis or for storage. 
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TRIGLYCERIDES: 
 
Source : totalpict.com/elevated triglycerides in accutane. 
Triglycerides are a group of lipids which contain a glycerol component esterified into 
3 fatty acid chains.  
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Source :www.123rf.com/triglyceride-optimised-molecular-structure 
Each chain can be saturated or unsaturated depending on the single or double bonding 
of the carbon and hydrogen atoms within these fatty acid chains. Triglycerides are the 
most abundant form of lipids found in the diet. It is acted upon by pancreatic lipase in 
the gut, which hydrolyses one fatty acid chain to release 2  free fatty acids and  one  2-
Monoglyceride compound. In response to lipids in the meal, cholecystokinin is 
released which stimulates the release of bile salts  into the duodenum. Bile salts 
combine with lipid molecules to form a hydrophobic core and a hydrophyllic surface. 
Absorption of these lipid particles takes place across the intestinal cell membrane by 
diffusion and also by the aid of lipid transporters.  Once, inside the cell, the free fatty 
acids and 2-monoglyceride particle reach the endoplasmic reticulum to form 
triglycerides again , which are then packed in the golgi apparatus into chylomicrons 
.These chylomicrons reach the circulation and are taken up by the liver (18). 
 
                                  
 
 
[27] 
 
                                        LIPIDS IN PREGNANCY 
 Pregnancy is a dynamic state in which Glucose, Free fatty acids, Long chain Poly 
unsaturated fatty acids( LCPFA) ,Amino acids , Minerals and Vitamins have to be 
continuously supplied to the fetus , inspite of intermittent food intake by the mother.  
Pregnancy is divided into two phases:   
Metabolic adaptations during pregnancy is essential : 
1.To ensure adequate growth and development of the fetus. 
2.To provide  the fetus with adequate energy stores and substrates that are needed 
following birth. 
3.To provide the mother with adequate substrates and stores to cope with the demands 
of pregnancy, labour and lactation. 
One of the metabolic adjustments is the accumulation of fat deposits in the maternal 
tissues during anabolic phase. 
ANABOLIC PHASE: 
During anabolic phase, the number of insulin receptors on the adipocytes increase 
                                                         Insulin sensitivity increases 
                                              Increased activity of Lipoprotein Lipase (LPL)    
                                                      Increased hydrolysis of Triglycerides 
                                                         Increased tissue uptake of lipids          Lipogenesis 
ANABOLIC PHASE
CATABOLIC PHASE
[28] 
 
There is increase in maternal fat deposition   (3.5 to 6 kg increase in body 
weight).This is to mainly spare the glucose for the fetus during the catabolic 
phase.Lean women have a higher increase in fat stores more than obese women due to 
insulin sensitivity. 
Important features of  fat  deposition   during Anabolic   Phase: 
1.There is hyperphagia which increases progressively as gestational age increases. 
2.Promotion of lipogenesis and suppression of lipolysis mediated by progressive 
increase in insulin (in early pregnancy there is increased response of pancreatic β cells 
to increase in glucose)and it’s sensitivity , enhanced by progesterone and cortisol.(19) 
3. The proportional increase in adipose tissue Lipoprotein lipase activity (20–
22)which hydrolyzes Triglycerides in the form of TG – rich lipoproteins, chylomicron 
and VLDL, which are converted to remnant particles and IDL.The hydrolytic particles 
,Non esterified fatty acids and Glycerol are taken up by subjacent tissues(23).    
4.The unique capacity of tissue to utilise intracellular glycerol released during 
lipolysis.     
During the last trimester there is a change to catabolic state. Placental growth 
hormone, Human placental lactogen , Leptin and TNF-α cause insulin resistance. High 
levels of these placental hormones have a net lipolytic effect. Maternal fasting 
hypoglycaemia enhances release of excessive catecholamines, along with increased 
secretion of Human placental lipase , insulin resistance by placental hormones lead to 
the net breakdown of maternal fat deposits. Non esterified fatty acids (NEFA ) and 
Glycerol are released as a result of the above mentioned lipolysis. These lipolytic 
products reach the maternal liver where they are converted into their active forms acyl 
[29] 
 
co –A and Glycerol-3 – phosphate  which are then  re esterified for the production of 
triglycerides which is then  released into the maternal circulation. Acyl co-A can also 
be converted to acetyl co –A for  producing energy and synthesis of ketone bodies. 
Glycerol is also used for producing glucose. Fetus uses glucose and amino acids 
maximally by 22-26 weeks which gradually decreases by third trimester by which 
time lipids are transported maximally for increasing the body weight. Hence the 
mother’s glucose is spared .Ninety percent  of  fetal fat deposition  ( 7g /day ) takes 
place  in the third trimester and human beings are born with the maximum percentage 
of fat 12-15 % compared to other animals.             
       
Source:www.msdlatinamerica.com 
During maternal fasting period, when the glucose is low, glycerol, released from 
lipolysis is utilised for gluconeogenesis(24).There is  accelerated release of ketone 
bodies during this period . Ketone bodies support  the fetus in 2 ways : 1. Ketones are 
used by the mother, glucose is spared for the fetus to utilise.2. Ketone bodies are 
[30] 
 
transferred efficiently to the fetal plasma   where it is used as oxidative fuel and for the 
brain lipid synthesis. 
The net breakdown of maternal lipids during the third trimester  corresponds mainly to 
an increase in Triglycerides , mainly in the LDL and HDL fractions , compared to 
other phospholipids and cholesterol (21,25). Other hormones also contribute to 
maternal hyperlipidemia in third trimester. 
Estrogen : 1.Increase in endogenous VLDL –TG(26). 
                 2.Decrease in adipose tissue Lipoprotein lipase activity(21,23). 
                 3.Inhibition of hepatic triglyceride lipase activity(23).     
Prolactin: Inhibits adipose tissue Lipoprotein lipase activity. 
Hence the combined effect of enhanced liver production of VLDL-TGL, decreased 
removal from circulation due to decreased Lipoprotein lipase activity, increase in 
CETP activity and decrease in Hepatic lipase activity ,increase in insulin resistance , 
increase in estrogen activity all lead to the net increase in accumulation of 
triglycerides in the third trimester. 
The lipoprotein Triglycerides do not directly cross the placental barrier.The 
lipoprotein TG are taken up by the placenta and transferred  to the fetus as  fatty acids 
by diffusion. The placenta selectively increases transport of essential Fatty acids and  
Long chain polyunsaturated fatty acids (LCPUFA) to the fetus.  The  Placental plasma 
membrane has fatty acid binding protein which preferentially uptakes only LCPUFA 
and transfers to the fetus. This is essential for fetal growth and nervous tissue 
development. 
[31] 
 
 
 
Source :www.frontiersin.org 
Cholesterol  is an essential component of cell membrane, precursor of bile acids and 
steroid hormones specially progesterone, precursor of oxysterol,  is needed for cell 
proliferation and differentiation. Cholesterol also acts as a mediator of metabolism 
through propogation of signalling cascades. It is essential in the propogation of ‘Sonic 
Hedgehog –SHH’ signalling responsible for the development  and patterning of the 
central nervous system(27–29). The average requirement of cholesterol per gram of 
body(fetal ) tissue is 1.5 mg whereas  per gram of brain tissue requires 7 mg,  making 
a total  requirement of around  8 gm for a 3.2 kg baby at term (30). The yolk sac and 
placenta play an important role in the feto maternal transfer of nutrients. The yolk sac 
develops after implantation of the embryo, by day 10 and slowly becomes non 
functional by the eighth week of pregnancy. The placenta becomes functional by the 
fourth week of pregnancy. 
[32] 
 
 Cholesterol  is made available to the fetus by the following ways: 1. Transfer from the 
maternal circulation. 2. Synthesis by the fetus. 
 Yolk sac : 
The vitelline arteries and veins form the vasulature of the yolk sac  and fuse with the 
fetal vessels within the developing embryo. 
 
Source : www.pnas.org 
The  yolk sac contains Lipoprotein receptors like Megalin, cubilin and SR-B1 for apo 
B,E – containing particles and for HDL(31–34).The yolk sac is also capable of uptake  
of particles without a receptor –dependent pathway(31,35). The lipoprotein cholesterol 
is then hydrolysed to free cholesterol , synthesis of new lipoproteins takes place and 
secreted into the vitelline vessels.The visceral endodermal cells of the yolk sac like 
enterocytes and hepatocytes are also capable of secreting lipoprotein. 
[33] 
 
The placenta: 
In the placenta, the maternal and fetal circulation are separated by a layer of 
multinucleated trophoblasts called the syncytiotrophoblast which forms a physical 
barrier. The trophoblasts are capable of taking up the cholesterol thro the lipoprotein 
receptors and also  through receptor independent channels. 
 
 
Source :intechopen.com 
The lipoprotein receptors found in the placenta are: 
(i)LDL receptor. (ii) VLDL receptor. (iii)Class A scavenger receptor .(iv) Class B 
scavenger receptors.The class A scavenger receptors are ; LDL –receptor related 
proteins, the apolipoprotein E receptor 2, megalin and cubilin .VLDL and LDL are 
taken up by apo E,B receptors .HDL is taken up by SR-B1 receptors. The  VLDL, 
[34] 
 
LDL and HDL particles are then taken up by the lysosomes where they are hydrolysed  
and then effluxed thro the basolateral membrane of the trophoblasts into the fetal 
circulation. Around 20 % of the sterol used by the fetus is from the maternally derived 
placental cholesterol. 
When the mother has low cholesterol levels as seen in abetlipoproteinemia , 
hypobetalipoproteinemia, low cholesterol diet, it does not affect the growing embryo. 
This is because ,placental sterol synthesis  increases to compensate for the decrease in 
transfer from maternal circulation(36–38).When the mother has high cholesterol , as 
normal physiological change, familial hypercholesterolemia, obesity and overt 
diabetes mellitus, the fetus responds by formation of fatty streaks in the fetal aorta 
which can predispose to atherogenesis later on in life.  If adequate maternal 
cholesterol is not available , fetus tends to be smaller and microcephaly can occur as 
seen in Smith –Lemli-Opitz Syndrome. 
In non pregnant state, higher concentration of VLDL-1 is seen in the immediate post 
absorptive state, failure of action of insulin and associated with increased  risk of 
Coronary heart disease.The concentration of VLDL-2 , precursor of   IDL and LDL 
does not change drastically. In pregnancy, though the concentration of triglycerides 
increased, the ratio of VLDL1:VLDL2  remained constant(23). Even though  the later 
part of pregnancy has altered lipid and lipoprotein levels, the hyperlipidemia seems to 
be ‘balanced’. 
During normal pregnancy , plasma TG increase by 200-400%, cholesterol by 25-50 % 
,total LDL mass by 70 %.The lipids are enriched with Triglycerides and depleted of 
cholesterol. 
[35] 
 
Though the hyperlipidemia of pregnancy is termed ‘physiological’, it is influenced by 
genetic factors, pre existing medical conditions, medical complications of pregnancy 
and other maternal factors. 
MATERNAL FACTORS: 
1.Obesity 
2.Maternal weight gain during pregnancy. 
3.Maternal nutrition. 
4.Pre pregnancy lipid levels. 
PRE EXISTING MEDICAL CONDITIONS: 
1.Type I /II Diabetes Mellitus. 
2.Hypothyroidism. 
3.Hypertension. 
4.Renal diseases. 
5.Alcoholism. 
6.Medications (LMWH,Glucocorticoid) 
MEDICAL COMPLICATIONS OF PREGNANCY: 
1.Pre-eclampsia. 
2.Gestational Diabetes Mellitus. 
3.IUGR 
[36] 
 
Physiological  hyperlipidemia, out of proportion can also lead to cholesterol 
gallstones, intrahepatic cholestasis, acute pancreatitis and Endothelial dysfunction. 
Failure to develop normal hyperlipidemia in pregnancy can lead to IUGR and future 
development of metabolic syndrome. 
As seen earlier, there is increased concentration of VLDL-1 TGL during 
pregnancy.VLDL is a major precursor of LDL and reflects on the circulating TG 
levels. These LDL particles undergo a reduction in the size by the action of hepatic 
lipase and become small , dense LDL subfractions. These  small dense LDL particles 
remain in the circulation for a longer period of time as they do not readily  bind to 
their receptors. They have a better capacity to penetrate the arterial intimal layer, 
easily oxidised (due to less concentration of vit E and other antioxidants).They are 
taken up by macrophages to form foam cells which initiates atherogenesis. So , the 
question arises, whether normal pregnancy is atherogenic ?  
Though  hypercholesterolemia is transient and limited to pregnancy, it triggers fatty 
streak formation in the fetal aorta which influences atherogenesis later in 
life(8).Autopsy studies revealed that offsprings  (between ages of 1-13 who died of 
trauma or other causes) of hypercholesterolemic mothers developed atherosclerosis 
much faster with 1.5 to 3 times larger lesions than offsprings of normocholesterolemic 
mothers as described by FELIC study (Fate of early lesions in Children study)(39). 
Umbilical cord blood samples from normal pregnancy showed a higher level of HDL 
and a lower LDL :HDL ratio as compared to the maternal blood  indicating that the 
fetus is protected against atherogenic lipoprotein(40). 
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 Lipids in pre eclampsia: 
Pre eclampsia is a specific vascular disorder unique to human pregnancy.It is a major 
cause for maternal and fetal morbidity and mortality.It is associated with placental 
dysfunction, oxidative stress ,endothelial cell activation and dyslipidemia.  
Dyslipidemia as characterised by increased TG levels , reduced HDL levels and 
increase in smaller, dense LDL (41).The risk of pre eclampsia increases significantly 
with associated conditions like Diabetes mellitus, chronic hypertension, 
thrombophilias and renal diseases , all of them have vascular endothelial 
dysfunction(42) . 
In pre eclampsia, there is reduced placental perfusion, acute atherosis in decidual 
vessels as shown by accumulations of foam cells and  perivascular mononuclear cell 
infiltration. Triglycerides increase two fold compared to normotensive women. 
Though the TG are high, effective transfer to the fetus is altered due to placental 
dysfunction. As mentioned earlier, maternal TG cannot cross the placental barrier. It 
has to be hydrolysed into Free fatty acids by the human placental LPL  which is 
subsequently transported to the fetus. In umbilical cord blood samples of babies born 
to pre eclamptic mothers, higher TG, higher LDL:HDL ratio and lower HDL was 
found.LPL expression was also enhanced in pregnancies with pre eclampsia and 
IUGR suggesting that adaptive mechanisms are at play to overcome the uteroplacental  
insuffiency and to ensure steady supply of fatty acids to the fetus. 
Serum triglycerides and VLDL was found to be significantly higher in women with 
pre eclampsia than normotensive women(43).Women with elevated triglyceride levels 
had twice the risk of developing pre eclampsia than women with normal values(44). In 
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another study, triglycerides measured at 28-32 weeks was most predictive of 
developing pre eclampsia later during the gestation(45). 
In IUGR, there is decreased concentration of Total cholesterol, triglycerides, VLDL 
and LDL leading to decrease in transfer of Glycerol, LCPUFA and essential fatty 
acids to the fetus(46). 
Lipids and infant birthweight: 
In 2011, Vinod.K.Misra studied the influence of variation in maternal serum lipid 
levels on variation in birthweight in obese and normal weight women. In obese 
women, they found a significant inverse relationship between HDL and birthweight of 
the fetus. Infants born to overweight or obese women had a significantly higher 
birthweight than infants born to normal weight mothers. In overweight mothers, 13 
gms decrease in birthweight was associated with 1mg/dl increase in maternal HDL 
concentration .In normal weight mothers, 6.4 gms decrease in birthweight was 
associated with 1mg/dl increase in maternal HDL.HDL has anti oxidant and anti 
thrombotic properties which influences placental circulation and fetal growth. 
Reduction in the circulating level of HDL may be associated with placental 
vasculopathy and increased risk of pre eclampsia(47). 
In 2001, Kitajima et al found that hypertriglyceridemia at 24-32 weeks of Gestational 
age was a significant predictor of having a large for gestational age baby at term 
independent of maternal glucose levels, obesity, pre pregnancy weight and weight 
gain during pregnancy(48). 
In 2002,Haggarty P et al postulated that >90 % of fat deposition in the fetus occurs in 
the last 10 weeks of pregnancy. Fetal blood is enriched with LCPUFA relative to 
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maternal supply. The placenta regulates it’s own Fatty acid substrates supply via the 
placental leptin on maternal adipose tissue. Fatty acids cross the microvillous and 
basal membranes by simple diffusion and by the action of membrane bound and 
cytosolic Fatty acid binding proteins. The direction and magnitude of fatty acid influx 
is dictated by the relative abundance of fatty acid binding sites. The placenta 
selectively transports important LCPUFA to the fetus by 1.Selective uptake by 
syncytiotrophoblast. 2.Intracellular metabolic channelling of individual fatty 
acids.3.Selective export to fetal circulation. Most of the LCPUFA accumulated by the 
fetus is stored in the adipose tissue for use in early post natal life(6). 
In 1999,  Sattar et al, found that median cholesterol, LDL, IDL values were lower in 
women with IUGR. One of the reasons being, these women had a low cholesterol in 
the first trimester itself. Normally there is a 60 % increase in mean cholesterol levels, 
mainly LDL by 35 weeks. When there is a failure in the above mentioned increase, 
either due to increased degradation of LDL or decreased synthesis of LDL, IUGR 
ensues(49). 
In pregnancies complicated by pregestational diabetes, gestational Diabetes mellitus 
and IUGR, there is an impaired transfer of LCPUFA from the mother to the 
fetus(50).There has been reports of normal LCPUFA concentration in the mother’s 
erythrocytes and plasma phospholipids but reduced in the plasma phospholipids of the 
neonate(51–53).This may explain the delayed brain maturity,  altered behavioural and 
intellectual development of the children , shorter attention span  and  motor 
dysfunction  at school age of children born to mothers with  pregestational Diabetes or 
gestational Diabetes mellitus(54). 
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In another study, in which lipids and lipoproteins were compared between normal 
pregnancies and pregnancies with ultrasound proven Intrauterine growth restriction, 
they  that Triglycerides, VLDL, LDL and  Total cholesterol increased gradually with 
gestational age , in normal pregnancies. Whereas in pregnancies with IUGR, all the 
above were found to be decreasing with advancing gestation.HDL did not show any 
significant change. Serum cholesterol and LDL was found to be significantly lower in 
women with IUGR babies(55). 
In a population of well controlled GDM pregnancies, circulating maternal lipids, and 
not glucose , correlated with weight of the fetus in the third trimester. Maternal free 
fatty acids and glycerol , measured close to term correlated with Large for Gestational 
Age fetus, than the mother’s BMI. In Small for gestational age babies, TG was high 
due to decreased adipose tissue mass leading to decrease in LPL activity. In LGA 
babies,high free fatty acids,high insulin to glucose ratio ( suggestive of in utero insulin 
resisitance ) and low TG levels were found(3). 
In 1999,Patrizia et al carried out a study to investigate the changes in circulating lipids 
and lipoproteins in normal and pregnant women. Triglycerides, LDL and Total 
cholesterol were significantly higher in pregnant women than non pregnant state. 
Changes in LDL during pregnancy might be used to identify women who would later 
develop atherogenic small dense LDL  to different stimuli , later in life(56). 
In 1997, Sattar et al studied 12 pregnant women to see the pattern of changes in the 
lipoprotein fractions throughout pregnancy. He found that there was a certain 
threshold in Triglyceride level beyond which  appearance of atherogenic small dense 
LDL –III particles accelerated.LDL-I increased by 2 fold, LDL-II by 40 %  and LDL –
[41] 
 
III increased 4 fold. This alteration in the increase of LDL-III was highest in women 
who had the highest triglyceride level at 10 weeks of gestation(23). 
In 2001,Sandra et al studied 250 pregnant women, to investigate the impact 
 of three Lipoprotein lipase polymorphisms & apoE genotypes on lipid levels in 
pregnancy. They found that S447X carriers had lower TGL,N291S carriers had lower 
HDL . The E2 allele was associated with lower TC,LDL compared to E3/E3 genotype. 
They concluded that severe triglyceridemia in late pregnancy is due to genetic 
mutations in genes of lipoprotein lipase or ApoE (57). 
In 1995, Nolan et al studied 388 pregnant women to identify the values of triglyceride 
measured earlier in pregnancy that will predict the development of Gestational 
Diabetes mellitus later in pregnancy. They found that Triglycerides measured between 
9-12 weeks correlated significantly with developing GDM later in pregnancy , more in 
Asian born women (3 times ) than Caucasian women. Triglycerides correlated 
positively with birth weight ratios of babies born, more  in Asian women than 
Caucasians(58). 
Maternal weight and Lipids: 
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In 2010, Vahratian et al , studied the effect of maternal pre pregnancy overweight and 
obesity on variation in lipid profile during pregnancy. They found that rate of change 
in LDL cholesterol and total cholesterol levels were lower in obese and overweight 
women than their normal weight counterparts. They speculated that the differences 
was due to metabolic dysregulation in overweight and obese mothers leading to 
adverse effects on the fetus as well(12).This is due to reduced action of hepatic 
triglyceride lipase activity which is responsible for converting the larger buoyant LDL 
subclasses containing more of cholesterol to smaller, dense LDL particles with more 
triglyceride content , as pregnancy advances. In non pregnant state, such a shift to 
triglyceride rich LDL particles is associated with atherogenesis, metabolic syndrome 
and diabetes. It is also considered as a systemic marker for low grade inflammation 
and vascular adhesion molecules(59).This shift to triglyceride rich LDL in overweight 
and obese women may also explain the increased risk of pre eclampsia in such 
women(60). 
Almost two in three women in the reproductive age group are overweight or 
obese(61). Metabolic changes in obese women may predispose to metabolic and 
cardiovascular diseases later in the life of the fetus(62).The complications of maternal 
obesity is mostly related to the pre pregnancy weight than the weight gain during 
pregnancy or the weight at term.The average weight gain recommended in pregnancy 
is as follows(63): 
Pre pregnancy BMI Recommended weight gain 
< 19.8 12.5 -18.0 
19.8 – 26.0 11.5-16.0 
>26.0-29.0 7.0-11.5 
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It was found that lean women gained a greater percentage of fat during pregnancy, 
more in peripheral tissues ( biceps and triceps area) than obese women(64).Increased 
incidence of diabetes and increasing maternal BMI has been associated with infants 
born with a birth weight greater than 90 th percentile (>4 kg )(65).Children born to 
obese mothers were twice likely to be obese by 2 years of age. If the mother had a 
BMI > 30  in the first trimester,  the prevalence of childhood obesity (BMI >95 th 
percentile), at 2 years was 15.1 %, 3 years was 20.6 % and at 4 years , was 24.1 
%.This was 2.5 times more than the obesity seen in children born to normal weight 
women(66). 
In women with positive screens for Gestational diabetes , but with normal glucose 
tolerance tests, maternal  pre pregnancy BMI and triglycerides measured in the third 
trimester correlated  significantly with infant birth weight (67). 
In another study ,maternal adiposity, pre pregnancy BMI and weight gain during 
pregnancy were found to be the strongest predictors of infant birthweight, more in the 
large for gestational age babies. Obesity in the mother is usually associated with 
chronic inflammation (increased CRP levels) and adipocyte dysregulation ( increased 
leptin and low adiponectin levels). Leptin and C-reactive protein correlated negatively 
with infant birth weight(68). 
Lipids and timing of delivery: 
In a study by Mudd et al, they found that extremely low total cholesterol, HDL  and 
LDL was aasociated with an increase in the risk of medically indicated preterm 
delivery ( as in pre eclampsia).High total cholesterol, LDL and triglycerides were 
associated with an increase in the risk of having spontaneous preterm delivery(11). 
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Lipid profile and adverse pregnancy outcomes: 
In a study, with data derived from Amsterdam Born Children and their Development 
cohort, fasting lipid profile in early pregnancy was correlated with the incidence of 
adverse pregnancy outcomes like Gestational hypertension, pre eclampsia, Small for 
gestational age babies, Large for gestational age babies, Pre term labour and fetal loss. 
They found that , for every unit increase in triglyceride taken in the first trimester , 
there was a significant increase in the  risk of developing gestational hypertension,  
Pre eclampsia and induced pre term labour. Total cholesterol was not associated with 
adverse outcomes(69). 
 
Source :www.pharmainfo.net 
The probable explanation being, elevated triglycerides in the early gestation may 
induce endothelial dysfunction.  There is increased peroxidation of these lipids 
,leading to oxidative stress releasing free radicals and lipid peroxides(70). These lipid 
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peroxides are toxic compounds that cause damage to endothelial cells(45).Hence , an 
elevated triglyceride can cause damage to the developing placenta ( at the time of 
angiogenesis ) , leading to future  placental vascular damages as seen in gestational 
hypertension, pre eclampsia and Intra uterine growth restriction. 
LONG TERM CHANGES IN LIPIDS  ( AFTER PREGNANCY): 
Lipid profile values reach their peak by 31-36 weeks of gestation. The percentage of 
increase from early gestation is as follows(71,72):  
               LIPIDS   % OF INCREASE 
Total cholesterol            43-53 % 
LDL            36-40 %       
HDL            0-25 % 
TRIGLYCERIDES           150-230 %     
 
After the delivery, total cholesterol and LDL cholesterol remain above the pre 
pregnancy values. Triglycerides fall rapidly. HDL remains lower than the pre 
conceptional value. These changes remain for several months , even up to an 
year(72,73). 
Prior studies have found an inverse relationship between increasing parity and lower 
HDL levels(74,75). The Coronary Artery Risk Development in Young Adults 
(CARDIA ) study, showed a decline in HDL for 2 years following  the first birth , but 
not for further pregnancies(76).In another study , examining the lipid changes in Black 
and White women, HDL values declined to -4 to -5 mg/dl  after the first birth. In 
women who were already parous,  there was no significant fall in HDL after multiple 
births. This proves that fall in HDL is maximum after the first birth and the effect 
persists much longer. Low HDL cholesterol (<40 mg/dl) is a strong independent 
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predictor of developing coronary heart disease(77). There is a 2-3 % decrease in the 
risk of developing coronary heart disease for every 1 mg/dl increase in HDL 
cholesterol(78). A 10 % decrease in HDL cholesterol over 12 years leads to an 
increase in the risk of coronary heart disease by 10 %(79). Hence a 6 % decrease in 
the HDL levels , post delivery may increase the risk of coronary heart disease by 6 – 
12 %. 
In another study by Mankuta et al, Lipid profile was studied prior to, during , after and 
in subsequent pregnancies. They found : 
     LIPIDS   I 
TRIMESTER 
II 
TRIMESTER 
III 
TRIMESTER 
POST 
PARTUM 
Total 
cholesterol 
Decrease of 
11.4 mg/dl 
Increase of 
50.5 mg/dl 
Increase of 28.5 
mg/dl 
In 1 year, 
returns to pre 
pregnancy 
level 
LDL 
Cholesterol 
Decrease by 
3.3 mg/dl 
Increase by 
25.9 mg/dl 
Increase by 19.4 
mg/dl 
Ist year 
returns to pre 
pregnancy 
values,further 
declines in 
2nd and 3rd  yr  
Triglycerides Decrease of 
13.3 mg/dl 
Increase by 
64.9 mg/dl 
Increase by 52.2 
mg/dl 
 
 No change Increase by 14 
mg/dl 
Decrease by 5 
mg/dl 
Levels 
plateau after 
first birth 
[47] 
 
The initial fall in the lipid profile values in the first trimester may be explained by the 
decrease in food intake due to the nausea and vomiting in the first trimester 
experienced by most of the women(21). 
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                              MATERIALS AND METHODS 
  TYPE OF STUDY : Prospective Observational Cohort study. 
  Scheme of research: 
Pregnant Women aged between 20-35 years, with singleton pregnancy 
attending antenatal OPD in CMC Obstetrics department were recruited  in the 
first trimester and followed up just after delivery. Morning fasting venous 
sample for lipid profile was collected in each trimester .Each sample was  
analysed for Total cholesterol, LDL, Triglycerides and HDL .Age, Socio 
economic status, Diet [vegetarian/non vegetarian], Pre pregnancy BMI ,blood 
pressure, fasting sugars ,Oral glucose tolerance test, weight gain in pregnancy, 
mode of delivery, incidence of adverse outcomes such as gestational 
hypertension and gestational diabetes mellitus,   are the other parameters 
which  were observed. Variations  in Total cholesterol, LDL,HDL and 
Triglycerides between each trimester were analysed .Birth weight of the 
infants born to these women was recorded . 
Inclusion criteria: 
• Pregnant women aged 20-35 years residing in Tamil Nadu/Andhra Pradesh. 
• Singleton viable pregnancy as confirmed by first trimester dating ultra sound. 
• Willing to participate in the study with informed consent and deliver in CMCH 
. 
• No prior history of chronic hypertension,diabetes mellitus and hypothyroidism.  
Exclusion criteria: 
• Multiple pregnancy. 
• Women with prior chronic hypertension,diabetes mellitus and hypothyroidism. 
• Who will not follow up in CMCH till delivery.  
[49] 
 
 
Variables analysed: 
1.Lipid profile :Non pregnant values                                    
Total cholesterol        <160 mg/dl[optimal]  
                                160-240 mg/dl [desirable] 
                                 >240 mg/dl[high] 
                                                                
LDL-C             <100 mg/dl[optimal]       
                         100-129[ above optimal] 
                         130-159[borderline] 
                         160-189[high] 
                                                                
HDL-C           >50 mg/dl [negative risk factor] 
                      <40 mg/dl[risk factor]                           
                                                              
Triglycerides    <150 mg/dl[optimal]    
                          200-499 mg/dl[high] 
                          >500 mg/dl[very high] 
 Lipid profile analysis was done in the Biochemistry department by the following 
methods 
Cholesterol:  ( CV of total chol  testing -2.2%)     Endpoint  enzymatic colorimetric 
assay with cholesterol esterase, cholesterol oxidase and peroxidise in Roche P800 auto 
analyser. 
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HDL: ( CV of HDL testing-2.8%) Colorimetric end point , enzymatic, anti b- 
lipoprotein  antibody in Roche P800 auto analyser 
LDL: (CV for LDL testing 6 %) Differential solubilisation with no pre treatment, end 
point enzymatic colorimetric assay, with cholesterol esterase ,cholesterol oxidase and 
peroxidise in Roche P800 auto analyser. 
Triglycerides: (CV of Triglyceride testing-3.5%) Colorimetric,enzymatic,end point 
lipase,glycerokinase,glycerol phosphate ixidase , peroxidase, in Roche P800 auto 
analyser. 
2.Socioeconomic status:    Modified Kuppuswamy scale (2005) 
   A       EDUCATION OF HEAD OF 
HOUSEHOLD 
                    SCORE 
 Professional degree                           7       
 Post graduate & above,BA or  B.Sc degree                           6 
 Intermediate or post high school diploma                           5 
 High school certificate                           4 
 Middle school completion                           3 
 Primary school or literate                           2        
 Iliterate                           1   
  
   B OCCUPATION OF THE HEAD OF THE 
HOUSEHOLD 
                  SCORE 
 Professional                        10 
 Semi professional                          6  
 Clerk, shop owner,farmer                          5       
 Skilled labourer                          4      
 Semi skilled labourer                          3 
 Unskilled                          2      
 Unemployed                          1               
 
  C PERCAPITA INCOME(Rs per month) 2005                     SCORE 
 >17,520                           12         
 8760-17515                           10        
 6570-8750                            5 
 4380-6560                            4 
 2628-4370                            3 
 885-2620                            2 
 <876                            1      
[51] 
 
 
 
3.BMI: 
BMI:  weight in kgs/height in cms2 . 
Height as measured in cms by a wall mounted stadiometer.  Weight as measured in 
Kilograms by bathroom weigh scale. 
 
4.Blood Pressure: Checked in each trimester, Right arm sitting position by a 
manual sphygmomanometer. 
5.Diet: Vegetarian /Non vegetarian. 
6.Birthweight of the fetus: Checked at birth, expressed in grams. 
7.Gestational Hypertension:   Defined as increase in Blood pressure >140/90 
mmHg on two occasions, 6 hrs apart detected after 20 weeks of pregnancy.(80) 
[52] 
 
8.Gestational Diabetes Mellitus:  fasting blood sugar ≥ 92 mg % at any 
gestational age. 
24-28 weeks, 75 gm Oral Glucose Tolerance Test (GTT),  atleast one value 
abnormal,(fasting ≥ 92 mg/dl or 1 hr ≥ 180 mg/dl or 2 hr ≥153 mg/dl)(81) 
9.Mode of delivery: Normal /Instrumental/LSCS. 
SAMPLE SIZE CALCULATION 
Sample size was calculated using the soft ware nMaster 2.0.The formula is   
“Hypothesis testing of two means” Based on the study by Retnakaran et al on the 
“effect of maternal weight,adipokines,glucose intolerance and lipids on  infant birth 
weight among women without gestational diabetes mellitus”, Research article in 
CMAJ ,May 2012.Triglycerides were  significantly associated with changes in birth 
weight(68). 
Standard Deviation in Group I (Low Birth weight)= 0.72 
Standard Deviation in Group II(High Birth weight)=0.66 
Mean difference in Triglycerides between the 2 groups= 0.24 
With an alpha error of 5 % and power of 80%, the sample size is 130 
Time period : January 2013 –November 2013  
Number recruited :130  
 
                                             
 
                                          
Figure 1.Overall distribution between three trimesters:
One hundred and thirty 
only 76 women were able to give their blood samples in all three trimesters. Out of the 
76, only 71  women had delivered within the time period of the study, 4 women were 
76 all 3 
trimesters
71 
BIRTHS
4 YET 
TO 
DELIV
ER
1 LOST TO 
FOLLOW 
UP
[53] 
RESULTS AND ANALYSIS 
 
 women were recruited after informed consent. Out of 130, 
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 yet to deliver and 1 woman was lost to follow up.
recruited women is shown in figure 
Figure 2.Age distribution:
The  age distribution among the women rec
are in the reproductive 
Figure.3 Socio economic status:
Socio economic scoring
Seventy Five percent ( N=98) belonged to the middle SES strata, fourteen percent 
(n=18) were in the high SES class and eleven percent (n=14) were in the low SES 
class.(Figure 3 ) 
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 Follow up details of all the other 
1. 
 
ruited is shown in figure 2 
age group  of  18-30 years. 
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 Figure.4 -Parity: 
Figure .4 shows the obstetric score of t
were multigravidas and  46 % 
Figure .5 -Diet : 
Figure.5 shows the diet distribution. 
vegetarians ( 93 %) 
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he enrolled patients. Fifty four percent (n=70) 
 (n=60) were primigravidas. 
Most of the women recruited were non 
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 Figure.6 -BMI Distribution
Figure.6 shows the Body Mass Index  (BMI ) distribution as 
Trimester. BMI was within the normal range in 33 % , 16 %
underweight group , 17 % 
the obese group .Baseline anthropometric values were missing for 5 women.
Figure.7-Weight gain in pregnancy(in kilograms):
Thirty six percent (n=34)
pregnancy, 28 %  had a weight gain
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 (I trimester ) : 
measured in the I 
 (n=21) 
 (n=22)  were in the overweight group, 31 % 
 
 
 of the women had a  weight gain between 
 of 5-10 kilograms,  19 %  had a weight gain
18.6-22.9 
normal
23-24.9 
overweight
>25 obese
43
22
39
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34
18
5.1-10 10.1-15 >15.1
 
were in the 
(n=39) were in 
 
 10-15 kg in 
 of  
 more than 15  kgs , 15 % 
Trimester weight was not available for 12 women who had delivered.
Figure 8 -Mode of delivery:
Figure 8 shows the mode of delivery for the women 
percent delivered normally,  16 % 
LSCS. 
 
               Variable    
Age of the participants
Gestational age at 
delivery(weeks ) 
Weight gain in 
pregnancy(kilograms)
 
 
LSCS
21
20%
INSTRUMENTAL
16
16%
[57] 
 had a weight gain of  less than  5 kgs . Data on  III  
 
enrolled in the study.
 had an instrumental delivery and 
                       Average value 
(years)                               25.5  
                              38.3  
 
                              10.7  
 
 
NORMAL
66
64%
MODE OF DELIVERY
NORMAL
LSCS
INSTRUMENTAL
 
 
 Sixty six 
 20 %  underwent 
Standard 
deviation 
4.17 
1.52 
5.41 
  
Figure 9 : Gestational age at delivery
Figure 9 shows the gestational
weeks. Only ten percent 
Figure .10- Sex of the babies born
  
Figure 10 shows the sex distribution of the babies born
was  almost an equal distribution of 
 
 
girls
53
51%
[58] 
 
 age at delivery. Ninty percent delivered a
delivered preterm (<37 weeks). 
: 
 to the study subjects 
boy and girl babies . 
90%
10%
>37 weeks
<37 weeks
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51
49%
 
t term >37 
    
. There 
boys
girls
  Figure .11-Birth weight distribution
Figure 11 shows the categorisation of babies as per birth weight . Categories were  
Low birth weight <2500 grams ,normal weight bet
gestational age (LGA ) as >
normal weight group, 14 % 
the low birth weight group.
Table.1- Anthropometry of the babies born
Parameter 
Birth grams 
Length( centimetres)
Ponderal index 
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ween 2501-3500 
3500 grams. Seventy three percent ( n=77) 
 ( n=15) were in the LGA group and 11 %
 
; 
Mean Standard 
deviation
              3027 555.48
 48.27 2.68
2.65 0.393
77
15
2501-3499 gms >3500 gms
grams, Large for 
were in the 
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 Table .1 shows the average birth
was 3027 grams,the average length of the babies born was 48 cm 
Figure .12 -Lipid Profile in I Trimester
Figure 12 shows the pattern of lipid profile done 
percent (n=70 ) had I trimester 
n=59) had a cholesterol value > 160 mg /dl which was considered as dyslipidemia.
Eighty nine percent (n=116)
percent had a triglyceride of > 150 mg /dl
Forty percent had normal  I trimester HDL valu
low HDL < 50 mg/dl, considered as dyslipidemia
three percent  had normal LDL val
trimester LDL values > 130 mg/dl considered as dyslipidemia.
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 Figure .13-Dyslipidemia in I Trimester:
Figure 13 shows the dyslipidemia
dyslpidemia in the I trimester ( cholesterol >160 mg/dl , triglycerides >150 mg/dl, 
HDL < 50 mg/dl and LDL >
Figure 14.-Gestational Diabetes Mellitus
Figure 14 shows the incidence of 
study..Thirty three percent (n=42) 
the remaining had normal glycemic profile.
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 in I trimester. Sixty three percent (n=82)
 130 mg/dl ) and  37 %  had normal lipid profile values.
: 
 
Gestational diabetes mellitus in the population under 
 of the women  were diagnosed to have GDM and 
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 Figure .15-Gestational hypertension
Figure 15 shows the incidence of 
enrolled.Ninty three percent 
diagnosed to have gestational hypertension.
Figure 16. Changes in cholesterol value over the three trimesters
Percentage change 
Figure 16 shows the pattern of increase in cholesterol from the I trimester , 
through II and  III trimester. The average value of cholesterol in I trimester 
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: 
Gestational hypertension in the women 
 had normal blood pressure  and only 7 %
 
__________30.5 %____________8%__________
Gestational 
Hypertension,
7, 7%
Gestational 
Hypertension
No gestational 
hypertension
Cholesterol1 Cholesterol2 Cholesterol3
157 199
157 I Trim
SD ± 27.8
199 II Trim
SD  ± 38.8
 
  were 
: 
 
 
216
216 III Trim
SD ± 40.8
 was 157 mg/dl, II trimester  was 199 mg/dl, III trimester 
values were calculated for the 76 women only , who had given all 3 lipid 
profiles. 
Figure 17. Changes in triglyceride value over the three trimesters
Percentage change____________84 %____________18%________________
Figure 17 shows 
trimesters.The average triglyceride in I trimester was 92 mg/dl, II trimester 
was 170 mg/dl and III trimester was 202 mg/dl.
Figure 18- Changes in HDL value over the three trimesters
Figure 18 shows t
of pregnancy.The average HDL in I trimester was 48 mg /dl, II trimester was 
52 mg/dl and  III trimester was 52 mg /dl.
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was 216 mg/dl. These 
the increase in the triglyceride levels over the three 
 
: 
he average values of HDL as measured in the three trimesters 
 
Triglyceride 1 Triglyceride 2
92 170.5
92 I Trim
SD ±39.6
170.5 II Trim
SD  ± 62.0
: 
 
 
Triglyceride 3
202
202 III Trim
SD ± 64.4
 Percentage increase __________8 %_____________0%_______________
. Figure 19. Changes in LDL value over the three trimesters
Percentage increase_____________37 %________________6%_______________
Figure 19  depicts the trend in the average LDL values over the three trimesters.The 
average LDL in I trimester was 94 mg/dl, II tr
was 137 mg/dl. 
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imester was 129mg/dl and III trimester 
HDL1 HDL2
48 52
48 I Trim
SD  ± 9.3
52 II Trim
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Change in HDL in 3 trimesters
LDL1 LDL2 LDL3
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94 I Trim
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52 III Trim
SD ± 11.5
±39.1
 Figure 20 Percentage of change between I & III trimesters :
Figure 20 depicts the percentage increase in lipid values from I to the III trimester. 
Cholesterol increased by 36 %, triglycerides 
LDL by 49 %. 
Table 2.Cholesterol profile in 3 trimesters
 
   Mean
 
Cholesterol I( 
mg/dl) 
 
   158
Cholesterol 
II(mg/dl) 
 
   203
Cholesterol III 
(mg/dl) 
   218
  
Table 2 shows the average cholesterol values in each trimester .
mean was 158 mg/dl with a SD of 27.8,  
38.8 and in III trimester ,the mean was 218 with a SD of 40.8.
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increased by 120 %, HDL by 7 % and 
 
     SD   Minimum
          27.8        77 
          38.8       120 
           40.8          138 
In I trimester, the 
in II trimester the mean was 203 with a SD of 
(p<0.00)
120.00%
7.00%
49.00%
change in 
Triglycerides
change in HDL change in LDL
 
 Maximum 
     248 
     383 
      345 
 
[66] 
 
Table 3.TRIGLYCERIDES: 
 
 
   Mean 
 
    SD   Minimum Maximum 
Triglycerides 
I(mg/dl) 
 
   100         39.6        40      335 
Triglycerides 
II(mg/dl) 
 
   178         62.0       87      620 
Triglycerides 
III(mg/dl) 
 
   212          64.4        113       558 
 
 Table 3 shows the average triglyceride values in each trimester .In I trimester, the 
mean was 100 mg/dl with a SD of 39.6, in II trimester the mean was 178 with a SD of 
62.0 and in III trimester ,the mean was 212 with a SD of 64.4.(p<0.01) 
.Table 4.HDL  
 
   Mean 
 
   SD   Minimum Maximum 
HDL I 
(mg/dl) 
   48    9.3        33      77 
HDL  II 
(mg/dl) 
   54   10.3        32      77 
HDL III 
(mg/dl) 
   54   11.5        34       85 
 
Table 4 shows the average HDL values in each trimester .In I trimester, the mean was 
48 mg/dl with a SD of 9.3,  in II trimester the mean was 54mg/dl with a SD of 10.3 
and in III trimester ,the mean was 54 mg/dl with a SD of 11.5.(p<0.01) 
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Table 5.LDL 
 
   Mean 
 
     SD   Minimum Maximum 
LDL I 
(mg/dl) 
   94        21.7        41      168 
LDL  II 
(mg/dl) 
   130         38.2        11      272 
LDL III 
(mg/dl) 
   142          39.1        69       255 
 
Table 5 shows the average LDL values in each trimester .In I trimester, the mean was 
94 mg/dl with a SD of 21.7,  in II trimester the mean was 130mg/dl with a SD of 38.2 
and in  III trimester ,the mean was 142 mg/dl with a SD of 39.1.(p<0.01) 
 
Variation between the three Trimesters: 
Table 6 : Mean change between Cholesterol in I, II and III trimesters done by the 
paired ‘t’ test. 
CHOLESTEROL  Mean Standard 
Deviation 
Significance 
Difference between  
I and II 
I 158 27.8 P  0.000 
II 203 38.8 
Difference between  
II and III 
II 203 38.8 P  0.001 
III 218 40.8 
Difference between  
I and III 
I 158 27.8 P  0.000 
III 218 40.8 
 
Table 6 shows the  mean change in the cholesterol values between the I & II trimester, 
between II & III trimester and between the I & III trimester with p value of <0.01 
showing significant change between the trimesters. 
Table 7: Mean change between Triglyceride in I, II and III trimesters   
          TGL  Mean Standard 
Deviation 
Significance 
Difference between  I 100 39.6 0.000 
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I and II II 178 62.0 
Difference between  
II and III 
II 178 62.0 0.000 
III 212 64.4 
Difference between  
I and III 
I 100 39.6 0.000 
III 212 64.4 
 
Table 7 shows the change in the triglyceride  values between the I & II trimester, 
between II & III trimester and between the I & III trimester with p value of <0.01 
showing significant change between the trimesters. 
Table 8 : Mean change in  HDL and LDL  across  I, II and III trimesters : 
 
          HDL  Mean Standard 
Deviation 
Significance 
Difference between  
I and II 
I 48 9.3 0.000 
II 54 10.3 
Difference between  
II and III 
II 54 10.3 0.168 
III 54 11.5 
Difference between  
I and III 
I 48 9.3 0.001 
III 54 11.5 
LDL  Mean Standard Deviation Significance 
Difference between  
I and II 
I 94 21.7 0.000 
II 130 38.2 
Difference between  
II and III 
II 130 38.2 0.004 
III 142 39.1 
Difference between  
I and III 
I 94 21.7 0.000 
III 142 39.1 
  
Table 8 shows the change in the HDL  values between the I & II trimester, between II 
& III trimester and between the I & III trimester with p value of <0.01 showing 
significant change between the  I & II , I & III trimesters.Between II & III trimesters 
HDL , p value was 0.168 , which was not significant. 
Table 8  also shows the change in the LDL  values between the I & II trimester, 
between II & III trimester and between the I & III trimester with p value of <0.01 
showing significant change between the trimesters. 
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Table 9.Correlation between birthweight and cholesterol in I , II & III trimesters 
.  Bi-Variate analysis was done with Pearson   correlation coefficients. 
                Birth  grams Chol 1 Chol 2 Chol 3 
Pearson Correlation co- 
efficient(r) 
-0.126 -0.382 -0.202 
Significance 0.303 0.001 0.096 
 
Table 9 shows the correlation between the birth weight  and  cholesterol values in all 3 
trimesters. There was an inverse  correlation between birth weight and cholesterol 
values in II trimester. 
 
Table 10 Correlation between birthweight and Triglyceride in I , II & III 
trimesters using Bi-Variate analysis 
               Birth grams TGL 1 TGL 2 TGL 3 
Pearson Correlation co- 
efficient(r) 
0.080 -0.080 0.014 
Significance 0.512 0.509 0.909 
 
Table 10 shows the correlation between the birthweight  and triglyceride values in all 
3 trimesters.There was a no correlation between birthweight and  triglyceride values in 
all three trimesters. 
 
Table 11 Correlation between birthweight and HDL  in I , II & III trimesters 
using Bi-Variate analysis: 
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               Birth grams HDL 1 HDL 2 HDL 3 
Pearson Correlation co- 
efficient(r) 
-0.218 -0.288 -0.217 
Significance 0.070 0.016 0.071 
 
Table 11  shows the correlation between the birthweight  and  HDL  values in all 3 
trimesters.There was a inverse  correlation between birthweight and HDL values in II 
trimester. 
Table 12 Correlation between birthweight and LDL  in I , II & III trimesters 
using Bi-Variate analysis 
                 Birth grams LDL 1 LDL 2 LDL 3 
Pearson Correlation co- 
efficient(r) 
-0.068 -0.339 -0.084 
Significance 0.578 0.004 0.489 
 
Table 12  shows the correlation between the birthweight  and  LDL  values in all 3 
trimesters.There was a inverse  correlation between birthweight and LDL values in II 
trimester. 
 ABNORMAL  LIPIDS AND  GESTATIONAL DIABETES MELLITUS: 
 Table 13.GDM & Triglycerides of I trimester 
 
This shows the proportion of women who had high triglycerides in I trimester and 
later on developed GDM . Among those who had high triglycerides ,there was no  
significant  statistical difference between those who developed GDM and those who 
did not. 
        TRIGLYCERIDES  Significance(Fisher’s 
exact test ) 
Normal <150 High >150 TOTAL             
             0.417 GDM GDM 25 4 29 
NO GDM 44 3 47 
TOTAL 69 7 76 
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 Table 14 .GDM & Cholesterol of I Trimester: 
 
 
 
This shows the proportion of women who had high cholesterol  in I trimester and later 
on developed GDM . Among those who had high cholesterol in I trimester ,there was 
no  significant  statistical difference between those who developed GDM and those 
who did not. 
 
 Table 15.GDM & HDL in I Trimester: 
 
 
 
This shows the proportion of women who had low HDL in I trimester and later on 
developed GDM . Among those who had  low HDL (N=46) in I trimester ,there was 
no  significant  statistical difference between those who developed GDM and those 
who did not. 
Table 16 GDM & LDL in I Trimester: 
 
 
 
        CHOLESTEROL  Significance(Fisher’s 
exact test ) 
Normal <160 High >160 TOTAL             
             0.059 GDM GDM 11 18 29 
NO GDM 29 18 47 
TOTAL 40 36 76 
                   HDL  Significance(Fisher’s 
exact test ) 
Normal >50 LOW <50 TOTAL             
             0.813 GDM GDM 12 17 29 
NO GDM 18 29 47 
TOTAL 30 46 76 
 
 
                   LDL  Significance(Fisher’s 
exact test ) 
Normal <130 HIGH >130 TOTAL             
             0.028 GDM GDM 24 5 29 
NO GDM 46 1 47 
TOTAL 70 6 76 
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This shows the proportion of women who had high LDL  in I trimester and later on 
developed GDM .There was   significant  statistical difference between those who 
developed GDM and those who did not, with I trimester LDL. 
Table 17 .GDM & MODE OF DELIVERY: 
 
 
 
 
This shows the proportion of women who had  GDM   and those who underwent 
LSCS. Among those who underwent LSCS ,there was no  significant  statistical 
difference between those who developed GDM and those who did not. 
Table 18 WEIGHT OF THE BABY & MODE OF DELIVERY: 
 
 
 
Normal <130 HIGH >130
NO GDM 46 1
GDM 24 5
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0.028
        MODE OF DELIVERY  Significance(Fisher’s 
exact test ) 
Normal  LSCS TOTAL             
             0.769 GDM GDM 20 5 25 
NO GDM 32 11 43 
TOTAL 52 16 68 
        MODE OF DELIVERY  Significance(Fisher’s 
exact test ) 
Normal  LSCS TOTAL             
             0.437 LGA <3500 42 15 57 
>3500 10 1 11 
TOTAL 52 16 68 
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This shows the proportion of   babies who weighed more than 3500 gms at birth and 
were delivered by LSCS .There was no  statistical significance  between mode of 
delivery and  birth weight > 3500 gms. 
 Table 19 .WEIGHT OF THE BABY & HDL IN I TRIMESTER: 
 
 
This shows the proportion of women with abnormal HDL in I trimester and had babies 
weighing more than 3500 grams. There was no   significant statistical  association  
noted between abnormal HDL and birth weight of the baby. 
Table 20.WEIGHT OF THE BABY & LDL IN I TRIMESTER: 
 
 
 
There was no significant statistical association between abnormal  LDL in I trimester 
and birth weight of the baby. 
Table 21 WEIGHT OF THE BABY & CHOLESTEROL IN I TRIMESTER: 
 
 
 
This shows the proportion of women who had high cholesterol  in I trimester and had 
babies weighing more than 3500 grams. Among those who had high cholesterol in I 
                  HDL  Significance(Fisher’s 
exact test ) 
Normal >50 LOW <50 TOTAL             
             1.000 LGA <3500 23 36 59 
>3500 4 7 11 
TOTAL 27 43 70 
                  LDL  Significance(Fisher’s 
exact test ) 
Normal <130 HIGH>130 TOTAL             
             0.580 LGA <3500 53 6 59 
>3500 11 0 11 
TOTAL 64 6 70 
             CHOLESTEROL  Significance(Fisher’s 
exact test ) 
Normal <160 HIGH>160 TOTAL             
             0.744 LGA <3500 32 27 59 
>3500 7 4 11 
TOTAL 39 31 70 
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trimester ,there was no  significant  statistical difference between those who gave birth 
to LGA babies and those who did not. 
 
 Table 22 WEIGHT OF THE BABY & TRIGLYCERIDES IN I TRIMESTER: 
 
 
This shows the proportion of women who had high triglycerides  in I trimester and had 
babies weighing more than 3500 grams. Among those who had abnormal triglycerides 
in I trimester ,there was no  significant  statistical difference between those who gave 
birth to LGA babies and those who did not. 
 
Table 23 .LOW BIRTH WEIGHT & HDL IN I TRIMESTER: 
 
  
This shows the proportion of women who had  abnormal HDL   in I trimester and had 
babies weighing less than 2500 grams. Among those who had  abnormal HDL  in I 
trimester ,there was no  significant  statistical difference between those who gave birth 
to  babies weighing less than 2500 grams  and those who did not. 
 
 Table 24.LOW BIRTH WEIGHT & LDL IN I TRIMESTER: 
 
 
             TRIGLYCERIDES  Significance(Fisher’s 
exact test ) 
Normal <150 HIGH>150 TOTAL             
             0.482 LGA <3500 55 4 59 
>3500 9 2 11 
TOTAL 64 6 70 
             HDL  Significance(Fisher’s 
exact test ) 
Normal >50 LOW<50 TOTAL             
             1.000 LOW BIRTH 
WEIGHT 
<2500 3 4 7 
>2500 24 39 63 
TOTAL 27 43 70 
             LDL  Significance(Fisher’s 
exact test ) 
Normal <130 HIGH>130 TOTAL             
             0.107 LOW BIRTH 
WEIGHT 
<2500 5 2 7 
>2500 59 4 63 
TOTAL 64 6 70 
[75] 
 
This shows the proportion of women who had  abnormal LDL   in I trimester and had 
babies weighing less than 2500 grams. Among those who had  high LDL  in I 
trimester ,there was no  significant  statistical difference between those who gave birth 
to  babies weighing less than 2500 grams  and those who did not. 
 
 Table 25: LOW BIRTH WEIGHT & CHOLESTEROL IN I TRIMESTER: 
 
 
This shows the proportion of women who had  abnormal cholesterol   in I trimester 
and had babies weighing less than 2500 grams. Among those who had  high 
cholesterol in I trimester ,there was no  significant  statistical difference between those 
who gave birth to  babies weighing less than 2500 grams  and those who did not. 
 
 
Table 26 .LOW BIRTH WEIGHT & TRIGLYCERIDES IN I TRIMESTER: 
 
 
 
This shows the proportion of women who had  abnormal  triglycerides   in I trimester 
and had babies weighing less than 2500 grams. Among those who had  high 
triglyceride  in I trimester ,there was no  significant  statistical difference between 
those who gave birth to  babies weighing less than 2500 grams  and those who did not. 
 
  
 
 
 
             CHOLESTEROL  Significance(Fisher’s 
exact test ) 
Normal <160 HIGH>160 TOTAL             
             0.692 LOW BIRTH 
WEIGHT 
<2500 3 4 7 
>2500 36 27 63 
TOTAL 39 31 70 
             TRIGLYCERIDES  Significance(Fisher’s 
exact test ) 
Normal <150 HIGH>150 TOTAL             
             0.482 LOW BIRTH 
WEIGHT 
<2500 6 1 7 
>2500 58 5 63 
TOTAL 64 6 70 
 Table 27.GDM & WEIGHT OF THE BABY:
 
 
This shows the proportion of women who had  GDM and had babies weighing  more 
than 3500 grams. Among those who delivered babies weighing more than 3500 grams   
,there was no  significant  statistical difference between those who had GDM and  
those who did not. 
 
 
 
Table 28 .WEIGHT GAIN 
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& WEIGHT OF THE BABY (LGA ): 
GDM NO GDM
1 10
24 35
24
35
1
10
GDM
                GDM  
    GDM NO GDM TOTAL 
 24 35 59 
 1 10 11 
 25 45 70 
                WEIGHT GAIN  
    <15 KG >15 KG TOTAL 
 48 8 56 
 6 3 9 
 54 11 65 
 
>3500
<3500
Significance
(Fisher's Exact Test)
0.083
LGA
Significance(Fisher’s 
exact test ) 
            
             0.083 
Significance(Fisher’s 
exact test ) 
            
             0.171 
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This shows the proportion of women who gained more than 15 kilograms   in 
pregnancy  and had babies weighing  more than 3500 grams. Among those who 
gained more than 15 kilograms  ,there was no  significant  statistical difference 
between those who gave birth to  babies weighing more  than 3500 grams  and those 
who did not. 
 Table 29 WEIGHT GAIN & ABNORMAL LIPIDS IN I TRIMESTER(LDL ): 
 
This shows the proportion of women who gained more than 15 kilograms   in 
pregnancy  and had  abnormal LDL in I trimester . Among those who gained more 
than 15 kilograms  ,there was no  significant  statistical difference between those who 
had high LDL in I trimester and those who did not. 
 
Table 30.WEIGHT GAIN & CHOLESTEROL IN I TRIMESTER : 
 
 
 
This shows the proportion of women who gained more than 15 kilograms   in 
pregnancy  and had  abnormal  cholesterol  in I trimester . Among those who gained 
more than 15 kilograms  ,there was no  significant  statistical difference between those 
who had high  cholesterol  in I trimester and those who did not. 
 
                 WEIGHT GAIN  Significance(Fisher’s 
exact test ) 
    <15 KG >15 KG TOTAL             
             0.579 LDL <130 
NORMAL 
48 11 56 
>130 HIGH 6 0 9 
TOTAL 54 11 65 
                 WEIGHT GAIN  Significance(Fisher’s 
exact test ) 
    <15 KG >15 KG TOTAL             
             0.742 CHOLESTER
OL 
<160 
NORMAL 
30 5 35 
>160 HIGH 24 6 30 
TOTAL 54 11 65 
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Table 31.WEIGHT GAIN & TRIGLYCERIDES IN I TRIMESTER : 
 
 
 
This shows the proportion of women who gained more than 15 kilograms   in 
pregnancy  and had  abnormal  triglycerides  in I trimester . Among those who gained 
more than 15 kilograms  ,there was no  significant  statistical difference between those 
who had high  triglycerides in I trimester and those who did not. 
 
Table 32 WEIGHT GAIN & HDL IN I TRIMESTER: 
 
 
 
This shows the proportion of women who gained more than 15 kilograms   in 
pregnancy  and had  abnormal  HDL in I trimester . Among those who gained more 
than 15 kilograms  ,there was no  significant  statistical difference between those who 
had  low HDL  in I trimester and those who did not. 
 
 Figure 33 .WEIGHT GAIN & LOW BIRTH WEIGHT : 
 
 
 
                 WEIGHT GAIN  Significance(Fisher’s 
exact test ) 
    <15 KG >15 KG TOTAL             
             1.000 TRIGLYCERI
DES 
<150 
NORMAL 
50 10 60 
>150 HIGH 4 1 5 
TOTAL 54 11 65 
                 WEIGHT GAIN  Significance(Fisher’s 
exact test ) 
    <15 KG >15 KG TOTAL             
             0.743 HDL >50 
NORMAL 
21 5 26 
<50 LOW 33 6 39 
TOTAL 54 11 65 
                 WEIGHT GAIN  Significance(Fisher’s 
exact test ) 
    <5 KG >5 KG TOTAL             
             1.000 LOW BIRTH 
WEIGHT 
< 2500 1 11 12 
>2500 5 49 54 
TOTAL 6 60 66 
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This shows the proportion of women who gained  less  than 5 kilograms   in 
pregnancy  and  delivered babies weighing less than 2500 grams . Among those who 
gained less than 5 kilograms  ,there was no  significant  statistical difference between 
those who had  babies weighing less than 2500 grams  and those who did not. 
 
 
Table 34 Factors influencing weight of the baby 
 
Logistic regression analysis was done to see if weight gain of the mother, cholesterol,  
HDL, LDL and triglycerides  in III trimester had an influence on the birth weight. 
 
 Variables Beta 
coefficient 
significance 95 % confidence interval  
Weight gain    25.17 0.01 5.52 44.83 
cholesterol -1.92 0.65 -10.29 6.49 
triglycerides 0.68 0.68 -2.6 3.95 
HDL -6.30 0.31 -18.6 6.08 
LDL 2.05 0.68 -7.86 11.97 
 
Beta coefficient refers to the amount of change in birth weight for an unit change in 
the factors affecting birth weight. Only weight gain of the mother showed a significant 
influence (p 0.01 ) on the birth weight of the baby.For every 1 kilogram increase in 
weight of the mother , there will be 25 grams increase in the birth weight of the baby. 
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Table 35.Correlation between percentage change in lipids between I & III 
trimester and developing GDM 
 
 
The above table shows no statistically significant correlation between the percentage 
change in lipid values (Cholesterol/Triglycerides/LDL) between I & III trimester and 
the risk of developing GDM. There is significant correlation between percentage 
change in HDL and developing GDM.                
 
 
 
 
 
 
 
 
 
                                            
Lipid 
profiles 
GDM p-
value 
No GDM GDM 
25th 
percentile 
Median 75th 
percentile 
25th 
percentile 
Median 75th 
percentile 
Cholesterol 20.41 33.96 50.78 21.35 37.95 59.33 0.65 
Trigycerides 65.63 114.63 166.42 60.93 146.36 196.7 0.31 
HDL 2.22 11.43 27.27 -10.53 4 14.29 0.03 
LDL 18.1 45.45 76 34.04 55.67 84.72 0.16 
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                                         DISCUSSION 
BASELINE DEMOGRAPHY 
Among the  hundred and thirty women who were recruited ,lipid profile was available 
for all three trimesters , only in  seventy six women. The most probable  reason could 
be , that these women went to their mother’s place after the first trimester for further 
antenatal care or they had adverse pregnancy outcomes like abortion, preterm labour 
etc for which they did not come to CMCH for medical  treatment.The mean age of the 
women recruited was 25.5 years. The majority  were in the reproductive  age group of 
18-30 years. The majority  ( 75 % )of the patients  enrolled were in middle 
socioeconomic strata and almost equal distribution in the high and low strata. 
 At baseline, 31 % of the women were in the obese group, 17 % in the overweight 
group  and only 34 % were in the normal BMI category. According to Indian statistics, 
5 % of our population are obese. According to the National Family Health Survey 
(NFHS), the percentage of ever married women aged 15-49 years who are overweight 
or obese increased from 11% in NFHS-2 to 15% in NFHS-3. Under nutrition is more 
prevalent in rural areas, whereas overweight and obesity are more than three times 
higher in urban areas. In south India the percentage of women who are overweight or 
obese is highest in Kerala (34%), followed by Tamil Nadu (24.4%), Andhra Pradesh 
(22.7%) and Karnataka (17.3%)(82).Overweight and obesity have been associated 
with development of diabetes, hypertension  and  cardiovascular events. 
In pregnancy , more than one third of women were found to be obese in the U.S. 
Obesity  leads to pregnancy related complications like gestational diabetes mellitus, 
gestational hypertension, pre eclampsia, higher rates of LSCS and  increased  post 
partum retention of weight. In the fetus,maternal obesity can lead  on to increased 
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prematurity, stillbirths, congenital anomalies, macrosomia, birth injuries and 
childhood obesity. They can have intra operative complications, anaesthetic 
complications, deep vein thrombosis and delay in initiation of breast feeding(85). 
The characteristic pattern  in lipid profile  among obese people, consists of elevated 
serum low-density lipoprotein cholesterol (LDL-C) and triglycerides and lowered 
high-density lipoprotein cholesterol levels(83,84) 
PREGNANCY  RELATED OUTCOMES : 
Weight gain in pregnancy: The average weight gain in pregnancy found in our study 
was about 10  kilograms which is less than the normal range of weight gain  ( 11-16 
kilograms for BMI between 18.5-24.9 ) recommended. About  57 %   of the 
participants had a weight gain between 5-15 kilograms. From previous studies, pre 
conceptional BMI of the woman , level of physical activity were the strong predictors 
of weight gain in pregnancy , more than genetic factors, age, parity and nutrition 
levels(86).Excessive weight gain in pregnancy has been quoted as the strongest 
determinant of maternal post partum weight retention, associated with long term 
weight gain , body adiposity and obesity – independent of age, predictor of high 
birthweight , macrosomia and overweight in infancy(87–91). 
Mode of delivery :  The majority ( 66 % ) of the women delivered vaginally and 
LSCS rate was 20 % which corresponds to our institution’s LSCS rate of 22-25 %. 
Timing of delivery : Most of the women delivered at term , only 6 % had a pre term 
delivery. The average gestational age at delivery was 38 weeks. 
Sex of the babies born : There was an equal distribution of boys: girls born  .The 
National sex ratio, girl : boy is  806 : 1000 , attributed to female infanticide and 
feticide(92). 
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Birth weight:  Seventy three percent  of the babies born were within the normal range 
of 2500 grams to 3500 grams. Fourteen percent (n=15) were over 3500 grams and  
eleven percent  were in the low birth weight group < 2500 grams. The   birth weight of  
average Indian  babies has been between 2500 grams to 2700 grams(93). 
BASELINE LIPIDS IN PREGNANCY: 
Dyslipidemia:   Dyslipidemia are disorders of lipoprotein metabolism, including 
lipoprotein overproduction and deficiency which is associated with obesity regardless 
of ethnic group. They may marked as one or more of the following: elevated total 
cholesterol, Low-density Lipoprotein Cholesterol (LDL), and triglyceride levels or as 
decreased High-Density Lipoprotein Cholesterol (HDL) level with promotion of 
insulin resistance causing metabolic syndrome in obesity(83). With the above 
criteria,63 % (n=82 ) of the women recruited were found to be dyslipidemic. Low 
HDL ,  defined as HDL < 50 mg /dl contributed  to the majority in the dyslipidemia 
group. Dyslipidemia in reproductive age group is usually associated with polycystic 
ovarian syndrome. Lifestyle modification with diet to control dyslipidemia , thereby 
reducing future cardiovascular disease risk has been well studied in men and women 
in non reproductive age group. 
In the Framingham study , the ratio of Total cholesterol : HDL was considered as 
excellent predictor of CHD risk with a hazard ratio of 1.21 for a 1.0 increment in 
ratio(94).In the Helsinki Heart study, LDL : HDL ratio , proved to be a better 
predictor of CHD , specially with associated hypertriglyceridemia. However , low 
HDL in this age group, may be an important predictor of CHD later in life. Lifestyle 
modification , with exercise, diet changes, cessation of smoking etc may alter the long 
term risks of development of CHD, if started early in life. 
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Gestational Diabetes Mellitus and Gestational hypertension:  
There was an incidence of 33 % of GDM seen in this study. In India, gestational 
diabetes mellitus was found to be complicating 16.5 % of pregnancies in 2004 (95) 
and the trend has been steadily increasing. We have recorded an incidence of 15 % in 
our CMCH obstetrics department .  With regard to lipid profile in pregnancy,  baseline 
LDL , mainly atherogenic small, dense LDL III fractions, was high in pregnancies 
complicated by GDM and showed a higher increase over the three trimesters 
compared to normal pregnancy(96). 
Gestational  hypertension was seen in six  percent of the women recruited. Worldwide 
the incidence of gestational hypertension has been 2-3 %  and  CMCH statistics show 
an incidence of  10-11 % . 
 CHANGES  IN LIPID PROFILE OVER THE THREE 
TRIMESTERS OF PREGNANCY  
Cholesterol: Total cholesterol ,showed an increasing trend from I to III trimester of 
pregnancy. The average percentage in increase was 36 % . This was little less than 
what has been reported in literature earlier, which was 43-53 % rise in cholesterol over 
the three trimesters of pregnancy(71,72). Also , there was  significant change in the 
mean cholesterol levels between I & II, II & III  and I & III trimesters of pregnancy. 
Triglyceride :  Triglycerides also showed an increasing trend as pregnancy advanced. 
The percentage increase , seen in this study was 120 %, compared to 150-230 %  rise 
,reported earlier(71,72). Also , there was  significant change in the mean triglyceride 
levels between I & II, II & III  and I & III trimesters of pregnancy. 
[85] 
 
HDL ;.  HDL showed an increase of 7 %  from I to III trimester . 0-25 % increase has 
been reported earlier, in other studies. There was  significant change in the mean HDL  
levels between I & II and I & III trimesters of pregnancy. But  no change between II & 
III trimester. 
LDL :  LDL also showed an increase in average value from I to III trimester of 49 % 
which was similar to  36-40 % increase ,reported in literature earlier. There was  
significant change in the mean  LDL  levels between I & II, II & III  and I & III 
trimesters of pregnancy. 
This pattern of increase in total cholesterol, triglycerides, HDL  and LDL throughout 
pregnancy is due to the relative insulin resistance that develops during the later half of 
pregnancy by the increasing placental hormones. There is a net breakdown of maternal 
fat deposits, leading to the increase in circulating lipids mainly triglycerides , which is 
essential for the growing fetus. 
SUMMARY : 
In answer to the first objective of the study   to assess the longitudinal variation in 
lipids between the three trimesters, there was a significant increase in the Total 
cholesterol, triglyceride, LDL and HDL cholesterol between the three trimesters of 
pregnancy . Only the change between the HDL values in II & III trimester , was not 
statistically significant as there was no observable  difference. 
 
 
[86] 
 
RELATION BETWEEN BIRTH WEIGHT OF THE BABY AND 
MATERNAL LIPID LEVELS. 
Birth weight of the baby is strongly determined by the neonatal fat mass. As 
mentioned  in earlier studies, maternal triglyceride , mainly in the II trimester  
significantly correlated with the birth of  LGA  baby(48). In well controlled GDM 
pregnancies, maternal lipids are the strong predictors of fetal lipids and fetal 
growth.Maternal FFA&TG measured close to term predicted LGA birthweight 
independent of maternal BMI(3). Among women without GDM, maternal adiposity & 
leptin levels were the strongest  metabolic determinants of LGA baby than glucose 
intolerance & lipid levels(68). Failure of the normal rise in LDL by 60 % in III 
Trimester is  found to be associated with IUGR(23). 
In our study we did not find any significant positive  association between maternal 
lipid profile ( in each trimester ) and the birth weight of the baby. Abnormal lipids in I 
trimester in the mother  did not have any  effect on the weight of the baby born. 
There was a negative correlation between weight of the baby and  II trimester 
cholesterol, HDL  and LDL.. 
SUMMARY 
In answer to the second objective, no significant   positive correlation was noticed 
between the lipid values in three trimesters and the birth weight. Negative  correlation 
was observed between II trimester cholesterol, HDL, and LDL values with the birth 
weight of the baby which is a new observation. 
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BIRTHWEIGHT AND OTHER FACTORS : 
Maternal weight gain , either a higher weight gain of more  than 15 kilograms or a 
lower weight gain of less than 5 kilograms did not affect the birth weight of the baby 
in a significant manner. There was no significant association between weight gain of 
the mother in pregnancy and  dyslipidemia in I trimester. 
By logistic regression analysis,   the linear weight gain  of the mother ,in pregnancy 
was the only factor that had a significant effect on the baby’s birth weight as 
compared to other factors like BMI, lipids and GDM. We found that , for every 1 kg 
increase in maternal weight , there was a 25 grams increase in the baby’s birth weight. 
In a study by Waters et al, where the neonatal body composition was correlated with 
the weight gain in the mother according to IOM guidelines, they found that, 
 increasing maternal weight gain during pregnancy significantly affects newborn fat 
mass, lean body mass, and percentage  body fat. Increasing gestational weight gain 
disproportionately increased newborn fat mass relative to the observed increases in 
newborn lean body mass or percentage body fat . For normal BMI women, gestational 
weight gain had significant effects on newborn adiposity. Gestational weight gain was 
not a significant contributor to newborn adiposity for overweight or obese 
women(102).  
LIPDS AND GESTATIONAL DIABETES MELLITUS /GESTATIONAL 
HYPERTENSION. 
In previous studies, hypertriglyceridemic dyslipidemia before  20 weeks of GA was 
associated with risk of developing early but not early onset severe pre eclampsia(99). 
Endothelial dysfunction , the primary pathology in pre eclampsia, has been found to 
persist even after pregnancy, leading to an increased  risk of CHD later in life. 
Dyslipidemia and hypertension are very closely associated with endothelial 
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dysfunction. Aberrations or an exaggeration of normal lipid profile changes , mainly 
an abnormally low HDL and a disproportionate increase in LDL has been observed in 
pregnancies complicated by pre eclampsia(100). In our study, number of women who 
developed gestational hypertension among those who delivered , in the study period 
was only 7. In view of the  small number, no statistical analysis was performed to find 
the association between lipid profile and  gestational hypertension. 
With regard to gestational diabetes mellitus, previous literature states that  
triglyceride, measured between 9-12 weeks was most predictive of developing GDM 
in that pregnancy more for Asian women(3 fold increase) than western born 
women(58).In women with positive diabetic screening in pregnancy, Maternal 
triglyceride was significantly associated with birth weight,  value >259 mg/dl was a 
significant predictor of LGA infants independent .of pre pregnancy BMI, maternal 
weight gain & fasting plasma glucose levels(48). Hypertriglyceridemia is the main 
lipid disorder in pregnant women with GDM, with a remarkable increase observed 
between second and third trimester(101). 
In our study , 33 % of the women enrolled were diagnosed to have gestational diabetes 
mellitus which is almost double the  incidence of GDM in our population which is 15 
%. However there was no significant association between linear  lipid profile changes 
in three trimesters and  occurance of GDM . There was significant increase in lipid 
profile between each trimester, but the percentage increase did not affect the 
development of GDM. Dyslipidemia in I trimester also did not show any significant 
prediction of developing GDM later on in pregnancy. 
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 SUMMARY : 
Though the incidence of GDM was high 33 % , in this study,  lipid profile in the 
women studied did not show  statistically significant correlation with the risk of 
developing GDM  and  had no influence on  the birth weight or mode of delivery. 
  
. 
                                     CONCLUSION 
1. There was  a significant increase observed, in the levels of total 
cholesterol,triglycerides, HDL and LDL between the three trimesters of pregnancy 
with triglycerides showing the maximum change. 
2. Significant number of women , 63 % were dyslipidemic even in the I trimester 
which is a depictor of non pregnant values. The major contributor was low HDL <50 
mg/dl, which is a potential risk factor for future cardiovascular diseases , hypertension  
and diabetes mellitus. 
3.Lipid profile across the three trimesters did not significantly affect the birth weight 
of the baby. 
4.There was no correlation between lipid profile changes and the risk of developing 
GDM in the women studied. 
5.The incidence of GDM was almost double , 33 %, compared to what is observed in 
the population in South India. 
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6. The incidence of overweight (17 %) and obesity (31 % ), at baseline was quite high 
compared to the reported prevalence of  obesity in 24 % of women in reproductive age 
group in South India. 
7.Weight gain in the mother ,was the only factor that showed significant correlation 
with birth weight .With every 1 kilogram  weight gain , there was 25 grams increase in 
birth weight of the baby. 
                                   
 
                                      LIMITATIONS 
1.Only 76/130 women enrolled in the first trimester , gave lipid profile in all three 
trimesters. Adequate follow up of all patients  enrolled ,was deficient as the patients 
were distributed between 3 obstetric units which had OPD functioning on different 
days . These women were seen by different doctors at each visit as they are rotated 
between units each month. Hence adequate numbers were not available to prove 
statistical significance. 
2. Only  one hundred and four  women had delivered before the time allotted for the 
completion of the study. This was due to late enrolment of patients. 
3. Lipid profile , taken in post partum period , after 6 weeks would have given us a 
picture of how many women continued to have lipid profile values in the dyslipidemia 
range.  
4.A detailed dietary history  of all the patients in each trimester ,would have given 
extra information to correlate with lipid levels and birth weight of the baby. 
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5. Family history of dyslipidemia was not taken into account to identify women with 
genetic predisposition to dyslipidemia. Physical activity of the mother was not 
considered or quantified. That would have  given more information on altering risk 
factors for dyslipidemia in the I trimester. 
6.Normal lipid profile reference  values  for  each trimester is  not available . Cut off 
values for dyslipidemia is only available for non pregnant population. 
 
 
                         FUTURE RESEARCH AVENUES 
 
1. To obtain normal reference values for lipid profile in pregnancy for each 
trimester and  to identify women who have abnormal values in each trimester 
of pregnancy, with a larger sample size. 
2. To identify factors predisposing to dyslipidemia in reproductive age group and 
provide appropriate health education regarding modification of life style, diet 
and physical activity. 
3. To provide long term follow up to the women who were dyslipidemic in I 
trimester and to identify early markers for development of diabetes, 
hypertension and cardiovascular diseases. 
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                                                   APPENDIX 1 
                                        PROFORMA       
                           LIPID PROFILE IN PREGNANCY 
1.Name                                    : 
2.Age                                        : 
3.Hospital number                 : 
4.Address                                 : 
5.Phone number                    : 
6.SES                                        :    Low  / Middle / High 
7.Parity                                    : G _ P_ L _ 
8.Diet                                       :     Veg / Non veg 
9.Height                                   : _____________ cms 
10.Weight                                    
                    Prepregnancy     : ______________ Kg 
           I Trimester                   : ______________ Kg 
         II Trimester                    : ______________ Kg 
       III Trimester                     : ______________ Kg 
11.Blood Pressure   
            I Trimester                    : ______________ mm Hg 
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          II Trimester                     : ______________ mm Hg 
         III Trimester                     : ______________ mm Hg 
12.Sugar Profile 
                      AC                         : 
                    GTT                         :_____ / ______ / ______ 
13.Mode of delivery                :Normal / Instrumental / 
LSCS    
14.GA  at delivery                    : __________ Weeks 
15.Sex of the baby                   : Boy  / Girl 
16.Birth weight                        : ___________ Gms 
17.Length of the baby            : ___________ Cms 
18.Lipid Profile 
  
    I TRIM 
 
    II TRIM 
 
    III TRIM 
Total 
Cholesterol 
   
 
      HDL 
   
 
      LDL 
   
 
      TGL 
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                                  APPENDIX 2                                
                             CONSENT    FORM 
Informed Consent form to participate in a research study :LIPID PROFILE IN 
PREGNANCY 
Study Title: 
Study Number: 
Subject’s Initials: _________ Subject’s Name: ________ 
Date of Birth / Age:_______Please initial box  
(Subject) 
(i) I confirm that I have read and understood the information sheet dated _________ 
for the above study and have had the opportunity to ask questions. (ii) I understand 
that my participation in the study is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my medical care or legal rights being 
affected.  (iii) I understand that the Sponsor of the clinical trial, others working on the 
Sponsor’s behalf, the Ethics Committee and the regulatory authorities will not need 
my permission to look at my health records both in respect of the current study and 
any further research that may be conducted in relation to it, even if I withdraw from 
the trial. I agree to this access. However, I understand that my identity will not be 
revealed in any information released to third parties or published. (iv) I agree not to 
restrict the use of any data or results that arise from this study provided such a use is 
only for scientific purpose(s) [ ] v) I agree to take part in the above study. [ ] 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
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                                         APPENDIX 3   
 
                                          ABBREVIATIONS 
1.HDL –High Density Lipoprotein 
2.LDL- Low density Lipoprotein 
3.IUGR-Intra Uterine Growth Restriction 
4.LGA-Large for gestational Age 
5.LSCS-Lower Segment Caesarean Section 
6.GDM –Gestational Diabetes Mellitus 
7.TC- Total Cholesterol 
8.TGL –Triglycerides 
9.FA-Fatty acids 
10.ACAT-Acyl Co A Transferase 
11.LCAT-Lecithin Cholesterol acyl transferase. 
12.CETP-Cholesterol Ester Transfer Protein 
13.LCPUFA –Long Chain Polyunsaturated fatty acid 
14.LPL-Lipoprotein Lipase 
15.BMI-Body Mass Index 
16.SHH-Sonic Hedge Hog signalling 
17.CHD-Coronary Heart Disease 
18.Kg-Kilograms
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                                                                                 Data of all Women Recruited 
s.no name cmch age ht wt wt_gain sys_bp_1dia_bp_1sys_bp_3dia_bp_3ac gtt_fastinggttt_1 gttt_2 mode_deliverysex weeks days birth_gramslength ponderalch_1 ch_2 ch_3 tg_1 tg_2 tg_3 hdl_1 hdl_2 hdl_3 ldl_1 ldl_2 ldl_3
1 ALMAS JABEEN 420602F 23 155 37 7 105 64 100 50 81 70 117 113 1 2 39 3 2,650 47 3 158 214 . 96 140 . 46 50 . 87 162 .
2 ANISA BEGUM 358311C 26 150 50 . 93 62 120 70 73 79 138 79 2 2 39 2 2,800 43 4 196 . . 107 . . 66 . . 118 . .
3 ANITHA 772814D 28 159 56 7 102 64 120 70 . 72 146 122 1 2 39 1 3,020 48 3 77 199 213 117 188 166 65 51 56 98 127 153
4 ANEES FATHIMA 399743F 23 153 59 13 110 70 120 70 85 78 82 132 1 1 40 1 2,980 49 3 140 214 211 79 180 220 45 67 60 83 11 128
5 ANEESHA NASREEN 794523D 21 160 39 17 118 77 120 80 94 77 105 98 1 1 39 4 2,880 48 3 120 . 241 40 . 137 45 . 65 64 . 168
6 ANITHA A 414588F 24 160 58 18 99 67 100 70 72 74 172 162 1 2 39 5 3,580 48 3 179 182 208 173 265 257 56 56 43 100 108 131
7 ARUNA 395029F 23 157 51 20 107 67 120 70 81 81 130 109 2 2 40 5 3,080 49 3 135 . . 164 . . 43 . . 70 . .
8 ASIYA 439967D 21 147 59 16 117 74 120 70 83 83 118 124 1 1 39 4 2,880 47 3 157 . 296 103 . 287 48 . 36 101 . 232
9 ASHA P 331096D 27 165 45 7 100 53 . . 90 . . . 1 2 34 6 1 37 0 126 158 . 75 162 . 53 47 . 62 91 .
10 ATHIQA  BANU 482868F 20 159 54 . 87 54 . . 92 . . . . . . . . . . 116 . . 55 . . 45 . . 61 . .
11 AYSHA KHANAM 418502F 20 158 63 13 113 69 160 110 . 67 86 116 1 1 38 1 2,580 47 2 138 199 180 82 125 176 43 61 49 86 132 114
12 BANUMATHI 610314C 33 173 68 9 103 65 120 70 95 . . . 1 1 38 4 3,070 50 2 150 184 188 151 193 243 37 48 45 94 120 126
13 BHARATHI 404012F 26 159 42 7 96 65 110 70 88 73 134 119 1 1 37 6 2,520 46 3 142 238 242 98 242 264 40 50 44 93 174 139
14 BHUVANA 939036D 25 150 43 9 105 69 110 80 72 . . . 1 2 39 4 2,390 47 2 144 198 186 102 163 186 57 73 59 77 100 112
15 BHUVANA 146870F 24 160 52 11 117 67 120 70 95 . . . 2 1 40 6 3,420 52 2 170 248 265 90 167 233 43 50 43 102 172 212
16 CAROLINE 993760C 35 160 67 . 120 80 . . 96 . . . . . . . . . . 147 . . 45 . . 47 . . 94 . .
17 CHANDRALEKHA 386534F 21 154 48 17 107 70 110 70 89 . . . 1 2 40 6 2,670 48 2 170 238 228 72 189 163 68 64 52 92 153 165
18 CHITRA C 578422D 25 154 60 14 109 70 120 80 89 81 121 113 2 1 39 1 2,920 48 3 136 186 164 82 140 152 57 65 60 70 103 92
19 CHELVI 383877F 23 165 64 16 98 68 110 60 92 77 116 109 1 2 40 2 3,420 50 3 163 . 238 92 . 260 62 . 49 87 . 134
20 DEEPA 069457F 22 155 53 . 106 67 120 70 81 108 120 105 1 1 37 4 3,150 49 3 247 269 . 183 218 . 56 56 . 166 190 .
21 DEEPA  S 386259F 21 163 59 20 97 65 110 60 91 . . . 1 2 38 . 3,200 50 3 148 131 . 138 296 . 49 43 . 94 56 .
22 DEEPA 795190C 24 168 65 21 102 65 120 70 76 80 113 92 2 2 39 2 3,600 50 3 184 242 231 116 249 351 77 64 62 101 156 143
23 DHANALAKSHMI 391582F 23 162 74 11 106 66 110 70 78 74 123 110 2 1 39 . 3,100 48 3 151 219 155 82 181 160 49 69 64 77 110 81
24 DHANALAKSHMI  G 473696F 26 152 63 . 95 66 . . 95 . . . . . . . . . . 142 147 . 88 133 . 36 42 . 91 93 .
25 DIVYA K 088528F 19 150 46 . 96 68 . . 77 . . . . . . . . . . 114 . . 74 . . 33 . . 73 . .
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26 DILSHATH THABASUM475359F 18 155 54 23 100 70 100 70 79 93 126 102 3 2 37 3 3,290 49 . 150 231 239 91 225 280 45 58 47 92 160 153
27 DIVYA 412156F 20 145 48 . 107 70 . . 74 . . . . . . . . . . 190 . . 130 . . 48 . . 118 . .
28 DIVYA 382952F 22 161 64 12 110 74 120 70 83 . . . 1 1 39 1 3,500 47 3 172 197 218 97 122 202 40 48 43 105 135 161
29 DIVYA 419691F 27 162 59 12 93 58 110 80 85 77 131 119 3 2 39 6 3,540 52 3 158 . 254 72 . 190 45 . 45 102 . 187
30 DURGASHI 942948D 28 157 81 . 118 80 . . 92 . . . . . . . . . . 167 214 206 144 170 169 38 39 34 107 161 153
31 FARJANA 752635D 26 154 63 . . . 120 70 80 87 147 108 1 1 39 3 3,320 49 3 189 . . 201 . . 35 . . 108 . .
32 FARIYA AMEEN 665162C 27 163 61 7 112 68 120 80 85 . . . 1 2 38 3 3,420 49 3 178 . 215 88 . 139 63 . 64 96 . 140
33 FATHIMA ARJUN 480258F 23 146 51 . 111 72 110 70 96 . . . 2 1 35 0 1,760 36 . 142 209 226 53 120 209 50 53 47 75 146 148
34 FOUZIA SULTANA 037871D 27 145 70 . 120 74 . . 92 . . . . . . . . . . 200 220 . 139 175 . 50 52 . 116 151 .
35 GEETHA LASKHMI 482895f 30 151 53 6 94 64 120 70 86 73 108 103 1 2 39 1 2,800 48 . 232 234 295 134 247 357 45 42 46 168 171 184
36 GUNA 395568F 27 150 57 14 99 61 110 80 89 88 158 118 1 1 39 5 3,660 52 3 133 160 187 79 137 171 35 40 39 75 104 132
37 HAJEERA 051311F 21 163 58 16 115 65 120 70 81 . . . 1 2 38 . 2,910 48 3 166 258 345 70 158 221 56 69 83 96 182 255
38 HAJIMA 675587C 34 151 53 9 120 80 120 70 83 85 136 111 1 2 40 2 3,320 51 3 181 255 260 92 147 171 59 54 51 124 191 205
39 HAMSA PRIYA 430765F 27 156 41 . 93 60 . . 71 . . . . . . . . . . 128 . 193 68 . 115 57 . 68 56 . 110
40 HEMALATHA 418283F 25 160 92 13 106 66 120 70 80 71 128 111 3 1 39 4 3,550 51 3 121 159 176 61 118 144 54 76 85 58 69 75
41 INDHUMATHI 254689F 22 152 37 . 82 56 . . 73 71 97 109 . . . . . . . 213 263 265 122 171 190 52 50 49 124 203 200
42 JAMUNA 155151F 24 167 61 11 99 61 120 70 86 88 173 125 1 1 38 6 2,960 46 . 161 191 196 123 120 197 56 71 73 83 109 90
43 JAYA SHREE 819221C 34 156 73 7 85 58 120 70 77 . . . 2 2 37 2 2,820 48 3 106 163 171 52 195 191 40 52 58 54 82 98
44 JOTHILAKSHMI 164686F 28 150 52 10 96 64 110 80 94 80 92 125 2 2 38 6 3,020 49 3 150 240 245 94 215 174 45 54 61 92 171 184
45 KALPANA 418455F 24 160 62 10 125 78 120 80 . 78 126 121 2 1 36 1 1,700 45 2 196 231 236 97 172 230 46 65 83 133 143 120
46 KANCHANA 871182D 22 152 43 13 86 54 100 60 69 67 81 91 1 1 39 1 3,200 49 3 162 233 . 86 164 . 46 57 . 93 156 .
47 KARPAGAM 416153F 24 160 54 18 113 70 110 70 85 80 163 158 2 2 40 3 2,800 49 2 165 201 223 78 204 301 49 58 56 105 135 140
48 KALAISELVI 868076D 34 147 60 15 110 70 120 70 90 78 133 . 3 1 39 . 2,820 48 3 118 185 191 81 147 316 41 65 58 66 110 101
49 KALAIVANI 494065F 20 154 54 14 105 69 110 70 82 76 84 74 3 1 35 5 2,870 49 . 126 173 . 92 159 . 33 45 . 69 110 .
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50 KAVITHA  N 398894F 25 167 55 . 96 66 . . 102 . . . . . . . . . . 113 . . 65 . . 43 . . 62 . .
51 KOMALA 891186D 27 150 53 10 106 68 120 70 94 86 127 89 1 2 39 1 2,750 48 2 163 . 196 94 . 259 63 . 51 91 . 122
52 KOMATHI 965404D 28 158 90 3 124 74 120 70 . 88 132 90 2 1 38 1 3,400 50 3 159 173 213 113 193 264 35 45 47 114 105 138
53 LAKSHMI 478733F 23 169 63 . 105 62 . . . 72 134 105 . . . . . . . 144 192 . 71 89 . 54 67 . 89 133 .
54 LALITHA 393287F 21 155 52 4 110 64 120 70 93 75 131 102 1 2 38 1 2,790 47 3 178 . 216 109 . 154 70 . 72 88 . 131
55 LATHABAI 021402D 31 156 70 3 103 61 120 80 94 . . . 3 1 38 6 3,440 50 3 127 157 138 103 162 156 38 40 40 61 79 69
56 LAVANYA 396744F 25 157 44 . 94 64 . . 96 . . . . . . . . . . 135 174 180 43 92 120 50 61 52 71 106 127
57 LAVANYA 392168F 25 155 42 10 98 67 116 70 . . . . . 1 39 2 2,750 47 3 150 179 211 107 198 223 43 46 43 101 109 133
58 LEKHA 473199F 27 153 59 . 96 62 . . 84 . . . . . . . . . . 131 . . 79 . . 49 . . 73 . .
59 MAHALAKSHMI 391489F 20 150 37 14 91 62 120 80 76 . . . 1 2 40 2 3,020 48 3 134 194 199 64 151 173 45 48 52 78 137 137
60 MAHALAKSHMI 200472F 27 159 53 13 100 74 120 80 88 77 123 107 1 1 38 2 2,640 47 3 142 142 141 73 114 166 39 48 47 79 79 75
61 MALA 022035C 35 158 66 9 118 82 120 70 87 89 207 176 1 1 40 1 3,430 50 3 164 178 162 156 172 225 38 51 49 97 97 93
62 MAMTHA 277612F 24 148 41 13 105 70 110 80 72 82 118 112 2 1 39 4 3,340 50 3 163 144 155 103 195 242 57 49 45 85 78 85
63 MANJULA 366421D 30 144 38 4 117 84 110 70 92 79 163 118 3 1 37 4 3,020 49 3 147 193 286 59 162 251 57 50 62 84 127 207
64 MANJULA SREENIVASAN391529F 25 150 51 5 117 72 130 80 97 . . . 3 1 34 2 1,970 42 3 150 192 155 81 148 125 48 49 41 90 135 102
65 MARY LAVANYA 450065D 27 150 58 . 96 69 . . . 86 174 119 . . . . . . . 179 169 177 164 244 223 60 54 64 103 91 94
66 MENAKA 455437D 30 162 59 . 89 56 . . . 88 . . . . . . . . . 170 . . 162 . . 41 . . 110 . .
67 MOHANALAKSHMI 413682F 18 159 33 12 105 61 90 60 78 . . . 1 2 39 3 2,880 49 2 108 217 256 57 116 196 39 73 74 61 145 169
68 MURUGESWARI 491884D 22 146 60 . 97 60 . . 70 88 136 101 . . . . . . . 133 168 . 125 222 . 34 46 . 67 84 .
69 MUTHURANI 395263F 20 151 41 . 100 67 . . 93 . . . . . . . . . . 150 . . 64 . . 58 . . 74 . .
70 NALINI 868420D 23 145 60 . 115 79 . . 81 . . . . . . . . . . 177 179 204 132 178 219 46 54 50 101 115 115
71 NALINI M 419058F 29 158 53 12 111 78 130 90 88 90 141 133 1 2 38 5 2,770 45 3 . 246 234 . 167 172 . 60 63 . 172 166
72 NANTHINI 410546F 22 155 41 5 97 62 120 70 93 80 140 94 1 1 38 2 3,140 49 3 140 225 238 84 175 207 47 46 41 79 154 168
73 NAZNEENSULTANA 721646D 27 149 58 8 97 60 120 90 83 80 138 157 3 2 39 . 3,140 49 3 180 205 221 85 131 139 57 60 72 100 130 138
74 NASEEMA SULTANA 372368F 27 155 48 12 113 74 120 70 91 . . . 1 1 39 2 3,110 50 2 110 167 . 57 163 . 62 43 . 41 105 .
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75 NIRMALA 425680F 33 155 43 -2 89 63 120 70 83 76 163 132 1 2 37 6 3,180 48 3 137 166 224 70 87 197 48 51 50 79 109 159
76 NITHYA 473191F 21 155 62 . 110 67 . . 89 . . . . . . . . . . 166 190 175 119 175 167 55 54 57 104 112 106
77 NITHYA LAKSHMI 382711F 26 165 62 16 94 62 100 70 91 . . . 1 1 40 . 3,100 49 3 183 270 300 53 165 210 57 60 61 109 199 230
78 POOVARASI 410067F 25 150 42 8 116 82 . . 89 76 188 171 2 1 33 6 1,880 43 2 173 222 . 91 221 . 54 32 . 110 170 .
79 PRABAVATHI 470856F 29 154 54 . 105 69 . . . 82 194 181 . . . . . . . 157 213 . 51 125 . 45 62 . 105 139 .
80 PRABAVATHI 478927F 24 165 63 . 105 72 . . 97 . . . . . . . . . . 152 . . 121 . . 37 . . 96 . .
81 PRIYA 418934F 26 149 73 12 112 76 120 70 71 79 165 136 2 2 39 1 3,020 48 3 168 193 188 142 177 172 34 44 46 97 142 131
82 PRIYADHARSHANI 869819D 25 157 57 18 86 57 120 70 87 93 141 109 1 2 38 5 4,060 52 3 144 192 . 74 93 . 55 73 . 71 120 .
83 PRIYANKA KUMARI 408991F 25 149 53 12 110 66 . . 89 83 189 166 1 2 34 3 2,190 46 2 248 383 317 335 620 558 49 55 36 144 272 208
84 RAJAKUMARI 388524F 25 165 60 6 108 67 120 70 81 82 137 120 1 1 39 5 2,780 48 3 193 216 220 82 137 197 68 73 73 112 110 123
85 RAJALAKSHMI 409363F 29 159 69 . 120 80 110 60 97 78 140 132 1 1 36 . 3,230 48 3 191 . 283 102 . 269 64 . 69 112 . 199
86 RAMADEVI 009481D 32 160 50 4 110 70 110 70 88 83 175 193 1 2 36 6 2,420 46 2 172 211 250 85 196 196 58 51 53 97 144 151
87 REKHA 398062F 24 151 52 11 105 68 110 70 94 89 151 149 3 2 39 3 3,280 50 3 174 230 231 110 223 245 57 59 58 102 160 148
88 REVATHI 392153F 26 157 59 6 126 76 130 90 95 88 141 106 2 2 39 2 2,940 48 3 192 262 266 147 222 271 53 52 56 124 182 198
89 REVATHY 529854D 23 158 62 -3 106 61 110 70 80 77 103 92 1 1 40 3 2,790 49 2 148 197 203 86 157 149 43 40 47 88 148 148
90 SANGEETHA 464614D 26 154 70 2 . . 120 70 80 89 140 101 1 2 39 4 3,100 46 3 152 175 193 86 162 167 42 45 49 96 119 132
91 SARASWATHI 645659D 30 165 53 12 103 62 100 70 . 89 177 87 1 2 38 6 3,400 50 3 163 208 . 82 180 . 55 53 . 102 145 .
92 SAMEENA 478393F 19 153 47 5 98 65 120 70 87 90 148 117 1 2 38 5 2,830 46 . 149 206 211 98 186 214 57 70 67 77 110 115
93 SANKARI 634385B 35 155 83 11 102 76 140 80 98 . . . 2 2 34 . 3,140 47 3 155 218 249 110 160 271 59 62 53 85 149 140
94 SARITHA 001364D 31 164 64 16 109 74 110 70 83 85 118 121 1 1 39 1 3,950 50 3 147 200 222 86 185 264 46 60 55 85 128 150
95 SANDHIYA 423912F 20 160 49 13 119 72 120 80 87 73 93 90 1 1 37 2 2,400 47 2 154 . 268 89 . 198 37 . 40 103 . 197
96 SANGEETA S 410685F 23 155 64 . 99 62 . . 86 . . . . . . . . . . 135 . . 76 . . 40 . . 94 . .
97 SARANYA 391408F 22 152 37 21 90 60 . . 84 81 146 129 1 2 40 1 3,250 49 3 192 260 . 115 251 . 48 49 . 109 172 .
98 SATHYA 322680D 29 164 74 2 124 75 140 90 90 76 101 106 3 2 39 5 2,900 49 2 178 . 260 101 . 195 55 . 68 104 . 192
99 SATHIYA 414608F 20 154 59 10 106 66 120 80 78 70 118 105 3 1 38 2 3,140 52 2 140 151 194 123 199 289 35 35 37 92 86 127
100 SATHIYA 896932D 19 157 66 2 107 65 130 90 . 79 174 156 1 1 37 5 3,460 49 3 191 234 310 91 155 270 46 44 49 136 176 228
101 SARANYA 385454F 21 164 51 13 117 71 120 80 85 84 113 125 1 1 40 5 3,170 51 2 126 200 215 71 146 199 40 61 62 71 112 132
102 SELVI 719256B 33 165 58 20 85 56 110 70 79 . . . 1 1 38 6 3,100 47 3 161 . 241 132 . 211 47 . 70 81 . 131
103 SHALINI 626838D 23 152 50 . 121 74 140 90 . 90 173 159 1 2 38 4 3,000 50 2 150 243 227 60 154 172 54 56 46 84 147 166
104 SHAMA 405680F 18 155 63 11 95 53 120 80 . 93 139 171 1 1 37 6 2,500 47 2 137 . 226 68 . 255 48 . 71 72 . 133
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105 SHAHEEN 473625D 28 157 79 11 100 66 110 60 88 83 151 116 1 1 39 . 3,600 50 3 172 192 191 133 184 183 46 53 56 112 121 123
106 SHAHANAZ 386140F 22 154 59 22 101 60 110 80 76 . . . 2 1 39 4 3,400 51 3 157 183 171 96 114 159 46 50 44 94 122 114
107 SHAKILA 947992C 32 152 59 -1 107 63 120 70 87 72 109 83 2 2 37 4 2,360 45 3 207 . . 75 . . 45 . . 148 . .
108 SHOBANA 909841C 25 163 97 . 116 70 . . 83 87 160 11 . . . . . . . 158 161 . 196 285 . 33 37 . 92 93 .
109 SHOFIYA SHAZEEYA 906593D 23 162 68 11 127 77 110 70 91 79 136 133 1 2 37 3 2,610 41 4 171 219 245 96 146 113 55 66 63 102 145 148
110 SHARMILA DEVI 437742C 29 156 70 . 103 68 120 70 84 85 123 143 1 2 39 5 3,720 50 3 155 153 172 131 241 228 46 50 52 93 81 100
111 SINDHUBIRAVI 392550F 27 162 35 9 87 61 110 70 84 72 142 139 1 1 39 2 2,310 49 2 185 259 246 76 137 156 74 77 65 102 177 156
112 SUBBULAKSHMI 411255F 28 162 47 7 90 60 . . 93 . . . 3 1 39 2 2,750 . . 208 226 241 143 195 224 55 50 52 138 168 168
113 SUMATHI 526238D 29 158 59 . 109 80 . . . 70 107 93 . . . . . . . 180 234 . 104 212 . 49 71 . 110 147 .
114 SUMITHA D 584717D 30 163 79 11 101 72 120 70 77 84 156 141 1 2 39 1 3,450 52 2 175 187 197 86 198 220 55 42 45 105 118 124
115 SUMITHRA 411114F 18 163 49 20 92 65 120 70 . 82 121 125 2 1 40 1 3,460 49 3 137 . 223 66 . 234 49 . 43 87 . 154
116 THAMIL SELVI 933247C 27 162 60 13 112 77 110 70 . . . . 1 1 39 6 3,730 51 3 159 182 227 67 162 239 52 43 39 94 121 150
117 THAMARAI SELVI 395266F 29 151 59 11 113 76 100 70 182 . . . 3 2 38 2 3,200 48 3 197 179 173 96 206 299 35 54 53 142 100 89
118 THANGAM 410615F 28 149 51 8 111 76 . . . . . . 1 2 40 . 3,420 49 3 148 . . 96 . . 47 . . 81 . .
119 THILAGA 899918D 32 159 57 4 111 77 110 70 83 80 153 92 3 2 39 2 3,074 49 3 155 203 198 78 145 119 57 61 66 89 131 124
120 THILAGAVATHI 387357F 27 155 41 . . . 120 70 83 78 115 76 1 2 38 5 2,370 46 2 165 190 . 103 150 . 66 72 . 84 108 .
121 UMA MAHESWARI 774252D 32 137 54 11 87 56 110 80 75 . . . 1 2 40 1 3,630 51 3 179 . . 160 . . 43 . . 121 . .
122 UMA 536250D 24 157 42 14 108 67 100 70 82 80 117 131 1 1 39 1 3,400 49 3 216 283 . 112 210 . 57 66 . 118 193 .
123 VASANTHA 098832F 23 159 47 . 91 61 . . . 60 143 68 . . . . . . . 109 . . 54 . . 43 . . 63 . .
124 VANI 592188D 20 157 55 9 94 62 120 70 76 75 143 127 1 2 40 2 4,550 53 3 151 157 170 184 202 260 33 47 42 98 94 106
125 VENNILA 175112F 31 160 61 9 96 67 110 70 . 73 144 104 3 2 40 2 3,380 50 3 165 199 211 99 153 160 38 52 54 114 125 136
126 VIDHYA 409207F 27 159 59 8 99 53 110 70 80 76 116 124 1 2 40 . 3,600 50 3 132 157 186 75 120 132 35 41 42 94 100 132
127 VIJAYALAKSHMI  343700D 28 157 60 16 101 67 110 70 79 76 167 97 1 1 40 2 3,580 50 3 188 223 . 129 153 . 47 50 . 124 153 .
128 VIJAYALAKSHMI 262238F 30 159 57 . 114 70 120 70 84 . . . 2 1 38 5 3,320 49 3 161 120 166 180 251 283 41 33 39 90 56 76
129 YASMEEN 505351C 31 153 64 1 98 71 110 70 92 108 162 169 1 2 39 1 2,930 49 2 166 231 229 109 182 214 45 48 47 97 164 160
130 ZUBITHA 433096F 22 147 38 . 101 64 . . 85 . . . . . . . . . . 142 . . 81 . . 52 . . 77 . .
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